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Background: Frailty, a state indicating vulnerability to poor health outcomes, is a common 
condition in later life. However, research and intervention progress is hindered by the current 
lack of a consensus frailty definition and poor understanding of relationships between frailty and 
depression.  
Objectives: The goal of this research is to understand the interrelationships between frailty and 
depression among older adults. Specifically, this project aims 1) to examine the construct overlap 
between depression and three definitions of frailty (biological syndrome, medical burdens, and 
functional domains), 2) to determine the degree to which this overlap varies by age, gender, 
race/ethnicity and other individual characteristics, 3) to evaluate how the association between 
frailty and depression influences prediction of adverse health outcomes. 
 vii 
 
Methods: This project uses data from the 2004-2012 Health and Retirement Study (HRS), an 
ongoing, nationally-representative cohort study of adults over the age of 55. Frailty was indexed 
by three alternative conceptual models: 1) biological syndrome, 2) cumulative medical burdens, 
and 3) functional domains. Depressive symptoms were indexed by the 8-item Center for 
Epidemiologic Studies Depression (CESD) scale. Latent class analysis and confirmatory factor 
analysis were used to assess the construct overlap between depressive symptoms and frailty. 
Latent growth curve modeling were used to evaluate associations between frailty and depression, 
and to estimate their joint influence on two adverse health outcomes: nursing home admission 
and falls. 
Results: The measurement overlap of frailty and depression was high using a categorical latent 
variable approach. Approximately 73% of individuals with severe depressive symptoms, and 
85% of individuals with primarily somatic depressive symptoms, were categorized as 
concurrently frail. When modeled as continuous latent factors, each of the three frailty latent 
factors was significantly correlated with depression: biological syndrome (ρ = .67, p <.01); 
functional domains (ρ = .70, p <.01); and medical burdens (ρ = .62, p <.01). Higher latent frailty 
trajectories were associated with higher likelihood of experiencing nursing home admission and 
serious falls. This association with adverse health outcomes was attenuated after adjustment for 
depression as a time-varying covariate. 
Conclusions: Findings suggest that frailty and frailty trajectories are potentially important 
indicators of vulnerability to adverse health outcomes. Future investigations of frailty syndrome, 
 viii 
 
however it is operationalized, should account for its substantial association with depression in 
order to develop more accurate measurement and effective treatment. 
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Chapter 1: Background 
 
The proportion of older adults in the US population is growing, and by 2030, 
approximately one in five Americans will be age 65 or older. The prevention of disability and 
unintentional injuries among older adults is a key objective for promoting health and well-being 
as part of the National Prevention Plan and Healthy People 2020 (1, 2). For example, falls affect 
one in three adults age 65 and older each year and are the leading cause of death due to 
unintentional injury among this age group (1, 3). There is increasing concern that acquired 
functional limitations and disabilities will increase the demand for long-term healthcare services 
in later life (1). As a result, increased emphasis is being placed on reducing the need for future 
formal and informal healthcare by promoting healthy lifestyles, strengthening physiologic 
reserve, and addressing vulnerability to adverse health outcomes before they occur (1, 2). 
Frailty as a geriatric syndrome 
Preventive approaches which target risk factors and or promote resiliency to physical 
challenges are thus primary means to prevent disability for older adults. Frailty is a geriatric 
syndrome that indicates multi-system susceptibilities to preventable injury and health decline and 
may be useful for targeting prevention efforts and allocating health resources. The identification 
and measurement of geriatric syndromes that indicate at-risk individuals are critical to prevention 
efforts because they are believed to be modifiable targets for timely intervention (4). Several 
approaches to reducing the prevalence and severity of frailty among older adults have been 
investigated with varying degrees of success (5). In clinical settings, care management of frail 
older adults is associated with lower mortality relative to usual care (6). Exercise training and 
nutrition interventions aimed at improving muscle strength and balance have had mixed success 
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at improving mobility and functional abilities among frail older adults in both institutional and 
home-based settings (7, 8). There is even suggestion that some pharmacologic agents may be 
viable treatments for addressing frailty symptoms. For instance angiotensin-converting enzyme 
inhibitors may be effective at slowing age-related muscle loss; however there is little clinical 
evidence to support the effectiveness of such treatments among frail individuals (9, 10). In sum, 
frailty may be an important tool for directing public health and clinical approaches to care among 
older adults and is a practical concept with broad applicability. 
Apart from being a treatable condition itself, frailty may be informative for determining 
other healthcare interventions. For instance, frailty has been used as a measure of suitability for 
surgery, medication, and transplantation (11-14). Frailty in this context may help vulnerable 
(frail) individuals avoid potentially harmful interventions, and at the same time, help ensure that 
healthy (non-frail) older adults receive beneficial care from which they might otherwise be 
excluded due to age. Frailty then can be seen as a more refined measure of physiological age that 
is not adequately captured by chronological age alone. However, adoption of frailty, whether as a 
screening tool or as a sign of poor physiologic reserve, is contingent on the validity and 
reliability of its measurement. 
The potential benefits of frailty as a marker of vulnerability are predicated on the ability 
to correctly and reliably identify older adults as frail. However, in practice, numerous distinct 
definitions and operationalizations of frailty are invoked depending on the context. Conceptual 
differences determine which domains, symptoms and dimensions are incorporated into the 
various proposed definitions (4, 15, 16). Frailty has been conceptualized as both distinct from 
and synonymous with comorbidity, disability, and functional limitations (17, 18). Indeed, the 
various existing definitions of frailty include symptoms that tap into psychological (19, 20), 
 
 
3 
 
cognitive (21-23), sensory (24), and even social domains (25-27). Still others suggest that a 
universally applicable definition of frailty is not possible and that frailty is simply a socially 
constructed entity (13, 28). It is clear from these contradictions that frailty is a concept still in 
development. 
Frailty and depression in later life 
It is unclear how the aforementioned concerns regarding the validity and reliability of 
current operationalizations of frailty impact the relationship between this syndrome and other 
health conditions in later life, particularly depression. Depression is an important example of a 
condition which shares many features and correlates with frailty. First, depression, like frailty, is 
a common disorder in late life. While the prevalence of major depressive episodes may be 
relatively low among older adults, the prevalence of clinically significant depressive symptoms 
is high and is highest among the oldest old (aged 85 years or older) (29, 30). This is often 
attributed to a greater prevalence of physical disability and cognitive impairment in later life 
(31). Second, frailty and depression may share common symptoms and predictors, and may 
predict similar vulnerability to poor health outcomes and mortality. Third, it has been argued that 
because of a high degree of comorbidity and conceptual similarity, that frailty and depression 
may be considered causes of each other, forms of each other, or even interchangeable clinical 
entities (32-39). Research has demonstrated that existing models of frailty and depression 
identify concordant populations more than expected by chance or by definitional overlap alone 
(33, 40). Older adults are more likely to report ‘somatic’ symptoms of depression such as sleep 
disturbance and fatigue (41), suggesting that frailty and depression may be forms of a similar 
vulnerability which increases with age. Antidepressant use is also associated with higher risk of 
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frailty incidence, suggesting that adverse effects of pharmacotherapy may contribute to risk of 
frailty, or that older adults with more severe depression are at higher risk of frailty (42).  
The complex and uncertain nature of the association between frailty and depression 
indicates the need for focused investigation of these constructs and how they jointly influence 
aging and health. There are many practical reasons to distinguish between and measure these two 
concepts. First, frailty may influence effectiveness of and adherence to treatments for depression 
or vice versa (43, 44). Second, comorbidity of frailty and depression may signal more complex 
health concerns that may not be adequately addressed by treatments focused on only one 
condition (15). Prior research has suggested that individuals with comorbid frailty and 
depression would benefit from more holistic care strategies that address both psychosocial and 
physiological vulnerabilities (45). Third, comorbid frailty and depression may be premorbid 
indicators of a more fundamental process of decline such as cardiovascular disorder or dementia, 
and so the co-occurrence of the two disorders may be of clinical value. Fourth, from a research 
standpoint, the investigation of these constructs may serve to bridge the gap between two parallel 
lines of research in frailty and late-life depression. Consideration of both constructs thus provides 
generative information for future research.    
This project aims to investigate the associations between frailty and depression and to 
describe their combined role in predicting and influencing health in later life using various latent 
variable techniques. Latent variable techniques are well-suited to investigating these questions 
because they help to account for measurement error inherent in studying syndromes which 
cannot be directly observed, like frailty and depression. Explaining the relationships and 
boundaries between these constructs is an important goal, because without these advances, a 
consensus frailty definition is less likely to emerge. By providing clarity about frailty as a 
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diagnostic entity we will aid future efforts to identify and intervene on frailty syndrome. 
Although frailty is a promising diagnostic and organizational construct for geriatrics, the real-
world benefits of being able to predict and prevent injury and disability among older adults will 
not be realized until conceptual and definitional issues are resolved. 
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Depression: Evidence from the Health and Retirement Study 
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ABSTRACT 
Objectives: To determine the measurement overlap of common definitions of frailty and depression 
and to investigate whether gender differences in symptom endorsement influence the degree of 
construct overlap. 
Design: Cross-sectional latent class analysis. 
Setting: Data come from the 2008 wave of the Health and Retirement Study, a nationally-
representative longitudinal survey of health characteristics among older adults. 
Participants: Community-dwelling adults aged 65 and older completing a general health 
questionnaire and consenting to physical measurements (N=3,665). 
Measurements: Frailty was measured using criteria developed in the Cardiovascular Health Study 
and depression was measured using items from the 8-item Centers for Epidemiologic Studies 
Depression (CESD) scale.  
Results: Frailty and depression were best modelled as two distinct but highly correlated constructs 
with 3-classes and 4-classes of symptom response respectively. Measurement overlap was high 
among both men and women. Approximately 73% of individuals with severe depressive symptoms, 
and 85% of individuals with primarily somatic depressive symptoms, were categorized as 
concurrently frail. The degree of construct overlap between depression and frailty did not 
significantly vary by gender, but women were significantly more likely to endorse all frailty and 
depressive symptoms.    
Conclusion: Findings suggest that common operational definitions of depression and frailty 
identify substantially overlapping populations of older men and women. More frequent 
endorsement of depressive symptoms, but not differential endorsement of somatic symptoms in 
particular, may contribute to the higher prevalence of frailty among women. Future research should 
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further describe the relationship between frailty and depression and focus on developing better 
means to discriminate between these constructs.     
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INTRODUCTION  
Frailty, a syndrome characterized by greater vulnerability to morbidity and mortality in 
later life, affects approximately one in 10 older adults (46-48). Frailty is increasingly recognized 
as an important predictor of disability and other poor health outcomes, including falls, 
hospitalization and mortality (4, 15, 18). One principal justification for distinguishing frailty as 
an independent health state is the potential to identify older adults prior to adverse events and to 
intervene to delay or prevent disability (4, 15, 18). However, conceptual disagreements about the 
components and symptoms that define frailty limit the ability of this syndrome to accurately 
identify affected individuals and to develop meaningful approaches to treatment (26, 48).  
The construct proposed by Fried and colleagues defines frailty as a syndrome of five 
biologic deficits distinct from comorbidity, disability, or a particular disease process (18, 26, 49). 
Previous research supports the existence of a phenotype characterized by co-occurrence of these 
deficits (50); however, the existence of this biologically-rooted phenotype does not preclude the 
predictive utility of additional non-biological criteria. Indeed, alternative definitions of frailty 
include symptoms that tap into psychological (19, 20), cognitive (21, 22), and sensory (24) 
domains (25, 26). These symptoms capture elements of biological age, psychosocial 
vulnerability, and medical morbidity, and, as might be expected with such a range of indicators, 
the different conceptual interpretations of frailty identify markedly different vulnerable 
individuals (48, 51); this in turn suggests that there may be distinct methods of effective 
intervention for these groups (48, 51).   
The frailty concept is additionally complicated by the potential inability of current 
operational schema to discriminate frailty from other geriatric syndromes such as depression 
(40). Like frailty, depression is a common condition among older adults and shares symptoms, 
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putative causes and possible outcomes with frailty (30, 32, 36). Predictably, the two conditions 
are highly comorbid among older adult populations, but the reasons for their co-occurrence are 
unclear (23, 33). Older adults with depression are more likely than younger adults to endorse 
somatic depressive symptoms such as sleep disturbances and fatigue (41), suggesting that frailty 
and depression may be correlated due to shared symptom profiles (akin to the acknowledged 
symptom overlap between depression and generalized anxiety disorder) (52). These two 
conditions may also represent alternate manifestations of a more general vulnerability to 
functional decline which increases with age (53). Despite purportedly measuring conceptually 
distinct constructs, emerging research has indicated that common operational definitions of 
frailty and depression identify highly concordant populations of afflicted older adults (40), and 
thus inferences about these conditions drawn from epidemiologic studies may be biased due to 
lack of measurement discrimination.    
Research exploring whether factors such as gender influence the degree of measurement 
overlap between frailty and depression is limited but warranted. Women are more likely than 
men to be identified as frail, regardless of the specific definition of frailty used, and tend to 
accumulate more physiological deficits with age (46, 54). Likewise, depression and depressive 
symptoms are consistently more common among women (55). Some attribute the gender 
difference in depression to the greater prevalence among women of ‘somatic depression,’ 
characterized by frequent endorsement of somatic, rather than cognitive or mood-related 
symptoms (56). The construct overlap of frailty and depression may therefore differ by gender 
due to differential endorsement of frailty and depression criteria.   
The purpose of this study is two-fold: 1) To confirm the extent of diagnostic  overlap 
between established indices of frailty and depression among a nationally representative sample 
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of older adults; and 2) To explore gender differences in the joint distribution of frailty and 
depression symptoms. We hypothesize that common indices of frailty and depression will 
identify highly overlapping populations, and predict that the degree of overlap and the types of 
symptoms endorsed will differ substantially between men and women.  
 
METHODS 
Data and Sample Characteristics 
Data for this study come from the 2008 wave of The Health and Retirement Study (HRS), 
an ongoing prospective survey of adults aged 51 and over, designed to assess the health, 
demographic, and financial characteristics of the aging population (57). As described in detail 
elsewhere, the HRS is a nationally-representative multi-stage probability sample (57). HRS 
respondents are interviewed every two years, and beginning in 2004, a subset of respondents was 
selected at each wave to participate in enhanced face-to-face interviews. The enhanced 
interviews include objective measures of physical characteristics such as height, weight, gait 
speed, strength, and other indicators of physical functioning (58).  
A total of 17,217 respondents were interviewed in the 2008 wave. Respondents were 
ineligible to participate in enhanced physical measurement interviews if they were currently 
residing in a nursing home (n=460) or interviewed by proxy (n=1,140). Of the 6,931 respondents 
who consented to enhanced interviews, 4,552 were aged 65 and over. The current study is 
restricted to the 3,665 respondents aged 65 and over who completed physical performance 
measures required to determine frailty status. Respondents who completed the physical 
performance measures were more likely to be women (t=3.44, p<.001), white (t=8.36, p<.001, 
currently married (t=6.50, p<.001) and to have more years of education (t=5.68, p<.001) 
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compared to those who were not included, but did not differ significantly with respect to age or 
employment status. 
 
Measures 
Frailty 
 Frailty was modeled using criteria derived from the Cardiovascular Health Study (CHS), 
including deficits in five areas: low weight, physical inactivity, exhaustion, weakness, and 
slowness (49). To the extent possible, operationalization of these criteria approximated or 
replicated CHS criteria. Low weight was defined as a self-reported or calculated loss of 10% or 
more in BMI since the previous (2006) wave or as a current BMI <18.5 kg/m2. Physical activity 
was calculated as the weighted average of self-reported frequency of three intensities of activity 
(mild, moderate, and vigorous); physical inactivity was defined as being in the lowest 20% on 
the physical activity score stratified by gender. In the CHS, exhaustion was indicated by 
endorsement of one of two items from the Center for Epidemiologic Studies – Depression 
(CESD) scale. Because the goal of this study is to examine the degree of diagnostic overlap 
between depression and frailty, we did not use items from the CESD to indicate frailty. We 
instead defined exhaustion as report of persistent or troublesome fatigue or exhaustion within the 
past two years. Grip strength of the dominant hand was measured using a dynamometer, and this 
value was then averaged across two measurements. Weakness was defined as being in the lowest 
quartile of grip strength stratified by gender. Although grip strength was not further stratified by 
BMI (as in the CHS) the gender-specific cut-points for weakness (male <29.5 kg; female <17.5 
kg) are consistent with CHS stratified measures and conservatively low (49). Gait speed was 
assessed using a 2.5-meter course; slowness was defined as a speed <.762 meters/sec for 
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individuals >159 cm in height, and as <.653 meters/sec for individuals ≤159 cm tall (49, 50). All 
frailty indicators were considered as binary (present/absent) symptoms. 
Depression 
 Depressive symptoms were ascertained using the 8-item version of the Center for 
Epidemiological Studies Depression Scale (CESD-8) (59, 60). The CESD-8 assesses the 
presence or absence of eight depressive symptoms over the previous week; positive items were 
reverse-coded (see footnote of Figure 2.1). Although the CESD-8 is not a substitute for diagnosis 
of major depressive disorder (MD), the CESD-8 has moderate agreement with the Composite 
International Diagnostic Interview (CIDI), a fully-structured diagnostic interview to assess 
presence of MD. In the HRS specifically, the CESD-8 has a sensitivity of .71 and specificity of 
.79 compared to the CIDI-assessed MD using a cut-point of CESD-8 ≥ 4 symptoms to indicate 
depression (59, 60).  
Covariates 
 Gender, race (categorized as non-Hispanic White, Black, or other), age (years), education 
(years), marital status (currently married vs. single/widowed/divorced), current employment 
status (full- or part-time vs. no employment), self-rated health (bad/fair vs. good/very 
good/excellent), and disability status (presence of any difficulties with activities of daily living 
(ADL) or instrumental activities of daily living (IADL)) were assessed by self-report. Cognitive 
functioning was assessed using number of correct responses (range: 0 to 10) to selected items 
from the Modified Telephone Interview for Cognitive Status (m-TICS) (61, 62).  
 
Analysis 
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 The bivariate associations between depressive symptoms and demographic 
characteristics, health indicators, disability status, and the five frailty indicators were examined 
using t-tests for continuous variables and Fisher’s exact tests for categorical variables.  
 Latent class analysis (LCA) was used to investigate the construct overlap between frailty 
and depression. LCA assumes the existence of an underlying categorical latent variable (i.e. 
frailty and/or depression) which explains the association between a set of observed variables (i.e. 
the respective indicator symptoms of frailty and depression) (63, 64). The purpose of LCA is to 
identify discrete subpopulations (classes) of individuals who share similar symptom endorsement 
patterns. LCA is appropriate for identifying syndromes, particularly in instances where there is 
no consensus as to scope of relevant symptomology. Given a specified number of latent classes 
and the values of observed symptoms, LCA uses an iterative maximum-likelihood method to 
obtain estimates of two types of parameters: 1) the proportion of the population belonging to a 
particular class (unconditional probabilities); and 2) the conditional probabilities of symptom 
endorsement given membership in a class. The set of unconditional and conditional probabilities 
for a given class describe the features of the class members. To account for the complex 
sampling design of the HRS, observations in all LCA models were weighted according to HRS 
sample weights indicating probability of selection into the HRS physical measures subsample 
(58).  
  We compared two general types of latent class model in order to determine whether the 
association between observed symptoms was best explained by a single latent construct or by 
two distinct constructs: 1) a single latent variable model in which all observed variables indicated 
a single latent construct (which would be consistent with frailty and depression being alternate 
forms of the same underlying syndrome), and 2) a model in which two separate latent variables 
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representing frailty and depression were indicated by symptoms from the CHS criteria and 
CESD-8 respectively (Figure 2.1). Within the second type of model, a series of additional 
models was fit, each specifying different numbers of classes for both depression and frailty. The 
explanatory strengths of these models were compared using goodness-of-fit statistics including 
Akaike Information Criterion (AIC), Bayesian Information Criterion (BIC), and sample-size 
adjusted Bayesian Information Criterion (BICN), for which smaller numbers indicate better 
relative fit. Goodness-of-fit statistics and interpretability of class features were used to determine 
the most likely model.  
 To examine differences in the joint distribution of frailty and depression symptoms by 
gender, we performed a multiple group LCA, comparing a series of models under different 
parametric assumptions. The procedure used for multi-group latent class analysis is described in 
detail elsewhere (65, 66). To summarize, first, the analytic steps described above were repeated 
independently among males and females to ascertain whether the appropriate number of latent 
classes was similar across gender. Second, in gender-pooled data, we evaluated the item-level 
measurement invariance of the model with respect to gender by comparing the fit of a 
heterogeneous (unconstrained) model to a homogenous model in which item-level conditional 
probabilities were constrained to be equal across gender. Third, we compared class proportions 
from item-level invariant and unconstrained models in order to evaluate whether class 
membership varied significantly by gender. The final, best-fitting measurement model was used 
to interpret latent class profiles and to compare class sizes across gender.   
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RESULTS 
 The characteristics of the analytic sample stratified by gender and depression status are 
shown in Table 2.1. Individuals who reported experiencing at least 4 CESD symptoms were 
significantly more likely to be women, to have less years of education and to be currently 
unmarried. Elevated depressive symptoms were also associated with presence of functional 
disability, lower cognitive performance scores, poorer self-rated health, and higher likelihood of 
endorsing all frailty criteria. Women did not differ significantly with men in presence of ADL 
disability, self-rated health, or cognitive performance scores; however, women were more likely 
to endorse all frailty criteria.   
   
Measurement Invariance by Gender 
 Table 2.2 displays fit statistics from selected LCA models assuming different numbers of 
classes for both frailty and depression. Models which treated frailty and depression as distinct 
but correlated latent variables defined by their respective indicator criteria (Figure 2.1) 
collectively achieved better fit to the data (indicated by lower fit-statistic values) than the single-
latent-variable model. In overall and gender-specific analyses, the model achieving the best fit to 
the data was one in which depression and frailty were represented by separate but correlated 
latent variables, with depression described by four latent classes (low, moderate, somatic, and 
severe depression) and frailty described by three latent classes (not frail, moderate frailty, and 
frailty with exhaustion). 
 To evaluate item-level measurement invariance by gender, we compared heterogeneous 
and constrained models as described above. The homogenous and heterogeneous models 
produced comparable fit to the data (BICN = 39486.439 and BICN = 39493.567 respectively), 
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indicating that conditional probabilities of symptom endorsement were similar by gender given 
membership in a particular class. Unlike conditional probabilities, unconditional class 
proportions varied significantly by gender (see Figures 2.2a and 2.2b), indicating that likelihood 
of membership in a particular class differed significantly by gender.  
 
Class Characteristics 
Figures 2.2a and 2.2b present class proportions and conditional probabilities of frailty and 
depression produced by the best-fitting model separately by gender. Conditional probabilities of 
the four depression classes were similar by gender (Figure 2.2a). Among both men and women, 
three distinct classes of depression characterized by low, moderate and high endorsement of all 
criteria were apparent. The fourth class, somatic depression, was characterized by endorsement 
of restless sleep, lack of motivation, and feeling activities were an effort. Women were more 
likely than men to be in the moderate or severe depression classes.  Frailty class conditional 
probabilities were also similar by gender (Figure 2.2b). The criterion of exhaustion distinguished 
the two classes with the greatest symptom endorsement; the criterion of low BMI did not 
discriminate between frailty classes among either men or women, as shown by similar 
conditional probabilities for all three classes. Women were more likely than men to be classified 
as moderately frail or frail with exhaustion. 
 Table 2.3 illustrates class overlap of frailty and depression. It is apparent from the table 
that membership in particular depression classes is associated with membership in the frailty 
classes. For example, among those in the low depression class, only 12.0% were classified in the 
moderate frailty class, and 0% were in the frailty with exhaustion class. Among those in the 
somatic depression class, 23.1% were classified as moderately frail and 62.1% were classified in 
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the frailty with exhaustion class. Similarly those classified in the high depressive symptom 
endorsement class (8.6%) were likely to endorse frailty symptoms, with approximately 73% 
classified as likely to endorse at least three frailty symptoms. 
 
DISCUSSION 
 The primary finding of this study is that commonly used criteria for frailty and depression 
identify highly-overlapping populations of older adults. Despite the fact that both frailty and 
depression are more common among women, there was no evidence that the measurement of 
these constructs differs by gender. We found that a substantial proportion of individuals 
categorized in the somatic or severe depression classes were also highly likely to meet criteria 
for frailty. This indicates that current measurement schema for frailty and depression syndrome 
may be poor at discriminating between these syndromes among older populations. The 
opportunity for misclassification and misattribution of symptoms given this substantial 
measurement overlap implies a need for considering frailty and depression jointly in 
epidemiologic study rather than as isolated conditions.   
 This study replicates recent work from our group that demonstrated substantial construct 
overlap between frailty, as defined by CHS criteria, and depression syndrome, as defined by the 
Diagnostic Interview Schedule (DIS) (40). In the present study nearly three-quarters of the 
individuals in the severe depression class were categorized in either the moderately frail or frail 
with exhaustion classes, compared to only 12% of individuals in the low symptom class. The 
consistency of overlap between CHS defined frailty and two different operationalizations of 
depression syndrome (DIS and CESD-8) suggests that the association between these two 
constructs may be explained in part by an underlying conceptual overlap or a common 
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underlying factor, rather than features of the measurement tool. For instance, Hajjar and 
colleagues have identified a potentially novel geriatric phenotype characterized by concurrent 
depressive symptoms, slow gait speed and impaired executive function (67). Similarly, our 
findings are consistent with the hypothesis that the co-occurrence of frailty and depression may 
be indicative of some common pathology, such as vascular damage to the brain. Vascular 
depression, a subtype of depression common among older adults and characterized by slowness, 
fatigue and muscular weakness, has been suggested as a prodromal state or early warning sign of 
frailty (38). In support of this hypothesis, we found that individuals in the somatic depression 
class were also highly likely to be considered frail, with 85% of individuals categorized in the 
moderate or frail with exhaustion classes.  
In addition to shared pathology, several hypotheses regarding a potential causal 
relationship between these conditions have been proposed. For instance, Lakey and colleagues 
found that anti-depressant use predicted incident frailty among older women independent of the 
association between depressive symptoms and frailty (42). However, as our findings suggest, 
even with longitudinal data the attribution of a causal relationship between depression and frailty 
is difficult due to measurement overlap. Though the CHS definition of frailty is primarily 
biological, excluding cognitive and mood-related symptoms present in other frailty definitions, it 
is nevertheless difficult to distinguish between this operationalization of frailty and depression 
(40).  
Overall, our findings indicate that analytic efforts to treat depression and frailty as 
independent constructs, or to exclude individuals with depression from studies of frailty is 
misleading and may bias the relationship between frailty and poor health outcomes. Given calls 
for a unified approach to conceptualizing and preventing geriatric syndromes (15), an alternative 
 
 
20 
 
approach toward the epidemiologic study of frailty would be to consider frailty and depression 
jointly as indicators of a more general vulnerability. For instance, recent evidence supporting the 
inclusion of cognitive impairment within the CHS frailty model demonstrates that the biological 
syndrome model of frailty is strongly correlated with criteria beyond those currently used (68).   
Consistent with previous research, we found that women were more likely than men to be 
classified as likely frail or depressed (46, 54, 55). Conditional item responses and class 
characteristics were similar across gender-specific analyses, suggesting that classes had similar 
meaning for men and women, and that gender differences are primarily due to the proportion of 
individuals in each class. We did not find that a substantially greater proportion of women 
belonged to a somatic depression class, in contrast to previous research (56). Instead, women 
were twice as likely as men to be classified in the severe (10.4 vs. 5.7%) or moderate (13.3 vs. 
6.8%) depression classes. Most previous studies regarding gender differences in somatic 
depression have used samples of younger adults (69-71), and thus differences between our 
findings and these prior studies may suggest that gender differences in the features of depression 
decrease with age. However, longitudinal data is needed to examine this hypothesis more 
directly. 
Our findings should be interpreted in light of study limitations. First, while the CESD-8 
asks respondents to report depressive symptoms in the previous week, some frailty criteria 
describe changes (e.g., weight loss) or represent average measures (e.g. physical activity). These 
differences in symptom time scale may have inflated the concurrence of depression and frailty 
syndromes; however, these results are consistent with prior work using the DIS in which the time 
scale of depressive symptoms was over a 6-month, rather than 1 week, period, and thus we 
believe our findings are not substantially influenced by differences in symptom time scale. 
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Second, the resulting classes from LCA are dependent on the specific metrics used to 
operationalize frailty and depression syndromes. The CESD-8, a short symptom inventory, may 
not evaluate all the depressive symptoms that are relevant to identify all meaningful classes. Our 
results are, however, consistent with previous studies using the DIS, a fully-structured interview. 
Strengths of this study include the large, nationally representative sample and use of LCA to 
empirically determine syndrome classes, rather than relying on a priori cut-points to define 
frailty and depression. With the large sample size, we were also able to examine whether gender 
differences in the prevalence of depression and frailty were due to measurement inconsistencies.    
Our study demonstrates that common epidemiologic instruments for measuring frailty 
and depression identify highly overlapping subgroups of affected individuals among both men 
and women. These findings have implications for the epidemiologic study of the predictors and 
consequences of frailty in late life, as well as the translation of research on this construct into 
clinical care. Future research should examine whether the co-occurrence of depression and frailty 
is due to a shared pathology, and whether this comorbidity has implications for poor health 
outcomes, including risk of disability, institutionalization, and mortality.  
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Table 2.1. Weighted sample characteristics by depression status and sex     
    Overall  
Elevated 
Depressive 
Symptomsa 
Non-Elevated 
Depressive 
Symptoms 
Women Men 
    (N = 3665) (N = 403) (N = 3262) (N=2,093) (N=1,572) 
    Weighted % or Mean (SD)b 
Demographics             
Female   55.52 67.01 54.03 --- --- 
Race             
White    90.77 88.26 91.1 89.84 91.92 
Black    6.21 7.4 6.06 7.06 5.15 
Other   3.02 4.33 2.85 3.09 2.92 
Age (years)   74.69 (0.14) 75.07 (0.45) 74.64 (0.15) 75.22 (0.19) 74.04 (0.20) 
Education (years) 12.63 (0.05) 11.33 (0.17) 12.8 (0.06) 12.39 (0.07) 12.93 (0.09) 
Married   56.02 41.82 57.85 41.91 73.63 
Currently Employed (PT/FT) 10.18 6.83 10.61 7.49 13.53 
Health Indicators             
TICS (≤ 8 correct items) 15.95 27.63 14.43 16.1 15.75 
Any IADL disability   12.44 32.09 9.9 13.57 11.02 
Any ADL disability   14.91 40.41 11.62 15.63 14.02 
Self-rated health (poor/fair) 25.78 63.46 20.91 25.65 25.94 
CES-D ≥ 4 Symptoms   --- --- 13.81 8.49 
Frailty Criteria (present)           
Low BMI   6.71 9.07 6.41 8.28 4.76 
Exhaustion   15.91 46.42 11.97 18.7 12.43 
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Slow movement   30.92 48.80 28.61 35.86 24.76 
Weakness   27.46 39.01 25.97 29.72 24.64 
Low energy 
expenditure 
  21.91 40.95 19.44 23.66 19.71 
Intermediate frailc   45.83 47.85 45.57 47.46 43.79 
Frailc   12.35 32.91 9.62 15.47 8.46 
aObservations are weighted according to HRS physical measures sample weight 
bElevated depressive symptoms are defined as ≥ 4 symptoms on the CESD-8. 
cBased on Fried et al. (2001) criteria. Subjects classified as frail if they endorsed 3 or more symptoms and intermediately frail 
if endorsing 1 or 2 criteria. 
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Table 2.2. Model fit indices from selected latent class models overall and by gender 
    
    Two latent variable models 
  
Model 1: 
Single latent 
variable with 
2 classes 
Model 2: 
Depression 3 
class; Frail 3 
class 
Model 3: 
Depression 3 
class; Frail 4 
class 
Model 4: 
Depression 4 
class; Frail 3 
class 
Model 5: 
Depression 4 
class; Frail 4 
class 
Model 6: 
Depression 5 
class; Frail 4 
class 
Model Fit Statistics       
AIC 37310.46 36319.13 36269.19 36044.04 35993.64 36035.86 
BIC 37478.04 36610.83 36610.55 36404.02 36409.48 36526.19 
BICN 37392.24 36461.49 36435.79 36219.73 36226.59 36275.16 
Women        
AIC 23090.75 22443.18 22411.57 22246.76 22204.59 22162.38 
BIC 23243.20 22708.56 22722.12 22574.25 22582.89 22608.44 
BICN 23157.42 22559.24 22547.38 22389.98 22390.03 22397.45 
Men        
AIC 14201.17 13865.67 13851.27 13810.95 13796.71 13771.33 
BIC 14345.90 14117.60 14146.07 14121.83 14155.83 14194.78 
BICN 14260.12 13968.29 13971.35 13937.58 13942.99 13943.81 
AIC: Akaike Information Criterion; BIC: Bayesian Information criterion; BICN: sample-size adjusted BIC; Smaller values 
indicate better model fit 
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Table 2.3. Overlap of class proportions from joint model of depression and 
frailty (Table 2.2, Model 4) 
  Total Women Men 
  3,665 2,093 1,572 
Depressive symptom class    
Frailty class    
    
Low  66.5% 61.0% 75.0% 
Not frail 88.0% 89.6% 88.0% 
Moderate Frail 12.0% 10.4% 12.0% 
Frail w/exhaustion 0.0% 0.0% 0.0% 
    
Moderate  11.2% 13.3% 6.8% 
Not frail 57.8% 58.7% 80.5% 
Moderate Frail 37.5% 38.6% 11.5% 
Frail w/exhaustion 4.7% 2.7% 8.0% 
    
Somatic  13.7% 15.3% 12.5% 
Not frail 14.9% 16.6% 11.4% 
Moderate Frail 23.0% 27.4% 21.6% 
Frail w/exhaustion 62.1% 56.0% 67.0% 
    
Severe 8.6% 10.4% 5.7% 
Not frail 27.1% 20.6% 44.4% 
Moderate Frail 2.8% 7.2% 0.0% 
Frail w/exhaustion 70.1% 72.2% 57.6% 
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Figure 2.1. Conceptual model of correlated latent constructs – frailty and depression 
 
 
 
 
Depressive symptoms include presence of the following symptoms much of the time within 
the past week: 1) felt depressed, 2) enjoyed life (reverse coded), 3) felt lonely, 4) experienced 
restless sleep, 5) felt happy (reverse coded), 6) felt sad, 7) felt everything was an effort, and 
8) could not get going.   
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Figure 2.2a. Depressive class proportions and conditional probabilities of symptom endorsement  
 
Figure 2.2b. Frailty class proportions and conditional probabilities of symptom endorsement 
 
  
Conditional probabilities and class proportions estimated from the joint modeling of 
depression and frailty (Table 3.2, Model 4). 
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Chapter 3: Depression and Frailty in Late Life: Evidence for a Common 
Vulnerability 
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ABSTRACT 
Objectives:  The purpose of this study is to estimate the correlation between depression and 
competing models of frailty syndrome and to determine to what degree the comorbidity of these 
syndromes is determined by shared symptomology.  
Methods: Data come from the 2010 Health and Retirement Study. Analysis was limited to 
community-dwelling participants 65 and older (N=3,453). Depressive symptoms were indexed 
by the 8-item Centers for Epidemiologic Studies Depression (CESD) scale. Frailty was indexed 
by three alternative conceptual models: 1) biological syndrome, 2) cumulative medical burden, 
and 3) functional domains. Confirmatory factor analysis (CFA) was used to estimate the 
correlation between depression and each model of frailty.  
Results: Each of the three frailty latent factors was significantly correlated with depression: 
biological syndrome (ρ = .67, p <.01); functional domains (ρ = .70, p <.01); and cumulative 
medical burden (ρ = .62, p <.01). Substantial correlation remained when accounting for shared 
symptoms between depression and the biological syndrome (ρ = .43) and medical burdens (ρ = 
.55) models.  
Discussion: Results indicate that the correlation of frailty and depression in late life is 
substantial. The association between the two constructs cannot be fully explained by symptom 
overlap, suggesting that a shared liability to both syndromes may determine their frequent 
comorbidity.  
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INTRODUCTION 
Aging is often accompanied by declines and deficits in multiple bodily systems. When 
deficits are significant or numerous enough, physiological reserve may be compromised, 
rendering older adults vulnerable to adverse health outcomes as a result of stressors or minor 
perturbations to physical health (5). Frailty syndrome is considered to be a marker of such 
vulnerability. Frailty is associated with higher incidence of adverse health outcomes such as 
falls, hospitalizations and mortality (16, 49, 72), and may be an important predictor of 
complications from surgery, medication use, and other common interventions (11-14). The 
prevalence of frailty in community-dwelling older adult populations is approximately 11%; 
however this estimate varies considerably depending on how frailty is defined, with estimates 
ranging from 4% to 59% (46). Among those age 85 and older, the estimated prevalence of frailty 
is approximately 26% to 44% (49, 54). The wide ranges reflect fundamental conceptual 
disagreements regarding the operationalization of this syndrome. These estimates also suggest 
that frailty, while common, is not an inevitable consequence of advanced age, leading to 
speculation about how it might be prevented or how it might inform health-related decisions and 
interventions.  
 Despite promise as a tool for prevention, frailty’s utility remains limited by conceptual 
and operational differences. Though there is implicit agreement that frailty is a condition 
conferring vulnerability, diverging explanations of how to define frailty result in substantially 
different empirical answers to the question “Who is frail?”. In a community-based sample of 
older adults, Cigolle and colleagues compared the diagnostic overlap of three frailty models 
representing three distinct conceptual approaches: 1) a biological syndrome model comprised of 
five specific physiological symptoms (49), 2) a cumulative medical burden index, characterizing 
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frailty as a state produced by accumulated medical burdens (72), and 3) a functional domains 
model, emphasizing deficits in specific functional abilities (24). Of the older adults found to be 
frail by at least one model, only 44% were designated as frail by at least two models and only 
10% by all three (48). The clear conceptual and diagnostic discordance between frailty models 
highlights uncertainty regarding the features that should be used to define it. Consequently, a 
range of potential symptoms, including physiological, cognitive, psychiatric, and sensory deficits 
have been incorporated into extant frailty definitions (19, 26, 68).  
 Another challenge to defining frailty is distinguishing it from other common conditions 
of later life, particularly depression. Like frailty, depression among older adults has been 
described in terms of diminished reserve capacity, representing a lack of coping resources to 
respond to mental or physical stressors (32, 73). For example, de Jonge and colleagues 
hypothesized that poor adjustment following somatic insult among depressed older adults may 
reflect inadequate psychological and social coping mechanisms, referring to depression as a form 
of “psychosocial frailty” (74). Depression and frailty are associated with similar outcomes, have 
similar risk factors, and, depending on the definition of frailty, share similar sympotomology (32, 
33). The two concepts are likewise difficult to disentangle in operational terms. Our previous 
work has shown that frailty and depression produced highly overlapping classification of 
afflicted individuals, even when correcting for chance categorical overlap (40, 75).  
The operational discrimination of frailty and depression is of both conceptual and 
practical concern. First, the validity of a measurement instrument is tied to its ability to 
discriminate distinct conditions from one another (76). The inability of frailty models to 
discriminate between frail and depressed individuals would indicate that current models are poor 
at measuring construct differences or, alternatively, that distinction between these constructs is 
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unwarranted. Second, treatment and prevention approaches for vulnerable older adults would 
differ based on the putative underlying nature of vulnerability, whether it is primarily 
psychological, physiological, or both. For example, adherence and pharmacodynamic response to 
anti-depressant medications may be worse among frail older adults (43, 44). When frailty and 
depression are comorbid, multimodal interventions targeting both depressive illness and 
physiological deficits concurrently would potentially be more effective than focus on a single 
area (45).  
  Arguably, the comorbidity of frailty and depression is similar to the comorbidity 
between common mental disorders (e.g. depression and anxiety) and presents similar challenges 
to research design. In epidemiologic studies of frailty, typical strategies for addressing this 
comorbidity are: 1) excluding individuals who meet criteria for depression, or 2) including 
individuals without regard for comorbid depression. Both strategies are problematic and may 
potentially lead to incorrect inferences regarding frailty and depression (77, 78). For instance, 
excluding depressed individuals from a study of frailty would yield a sample of frail individuals 
who are non-representative of frail older adults and, importantly, who are less severely impaired 
(77, 79). On the other hand, ignoring comorbidity in this context would make it difficult to 
distinguish whether outcomes were related to frailty, depression or the interaction of the two (77-
79). As the validity of frailty models is often tied to model prediction of outcomes like falls, 
hospitalization and mortality (21, 49), this problem would conceivably impact the comparative 
effectiveness of alternative frailty definitions.  
Reflecting these limitations in the extant literature, in this study we aim to determine the 
correlation between depression and frailty conceived as latent dimensional factors using 
confirmatory factor analysis (CFA). By using a dimensional approach, we address limitations 
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introduced by viewing frailty and depression as dichotomous or categorical conditions. Instead, 
frailty and depression are conceived as extreme points on continua of physical and psychological 
functioning. Substantial correlation between the two constructs is indicative of a higher order 
factor (or liability) which influences likelihood of both frailty and depression. Such a finding 
would provide clarity to the discussion of comorbidity and would help inform future attempts to 
refine the definition of frailty. To investigate whether operational differences play a role in the 
relationship between frailty and depression, separate analyses will be performed for each of the 
three frailty models identified by Cigolle and colleagues. We expect that the correlation of frailty 
and depression will be substantial but will vary considerably based on different specifications of 
frailty criteria. 
METHODS 
SAMPLE 
 This study is based on data from the 2010 wave of the Health and Retirement Study 
(HRS), a prospective survey of older adults begun in 1992, designed to collect longitudinal 
information on the health and finances of older Americans. The HRS employs a multi-stage 
probability sample of US households to produce a nationally-representative sample of adults age 
51 or over (57). Self-reported information regarding demographics, chronic health conditions, 
daily activities, disability status, health insurance and other determinants of health are collected 
at baseline and at subsequent two-year intervals. Beginning in 2004, a randomly-selected subset 
of HRS respondents participated in enhanced face-to-face interviews which included objective 
assessment of walking speed, hand strength, weight, height and other physical measures (58).  
 Respondents aged 65 or older at the time of interview were considered eligible for the 
study. Respondents were considered ineligible if they were interviewed via a proxy or if they 
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resided in a nursing home at the time of interview. The primary analytical sample was restricted 
to respondents who were selected for the enhanced face-to-face interviews and completed or 
attempted physical measures tasks (grip strength and walking speed) used in the calculation of 
frailty scores. Sensitivity analyses were conducted to evaluate potential influence of excluding 
individuals with missing physical measures data.  
 The HRS is approved by the Institutional Review Board (IRB) at the University of 
Michigan, and this analysis received exempt status from the IRB at Virginia Commonwealth 
University. All participants provided informed consent. 
MEASURES 
Frailty 
Biological Syndrome 
 The biological syndrome model of frailty was operationalized using five criteria proposed 
by Fried and colleagues in the Cardiovascular Health Study (CHS): low weight, physical 
inactivity, exhaustion, weakness, and slowness (49). Low weight was defined as a loss of 10% or 
more in BMI since the previous (2008) wave or a current BMI <18.5 kg/m2. Physical activity 
was calculated as the average frequency of three activity intensities weighted by average 
metabolic equivalency of task (MET) scores: mild (1-3 MET), moderate (3-6 MET), and 
vigorous (6-10 MET). Participants were considered physically inactive if they scored in the 
lowest 20% of average physical activity. Exhaustion was specified in two ways: 1) using items 
from the Center for Epidemiologic Studies – Depression (CESD), as in the original CHS 
operationalization, and 2) as self-reported persistent or troublesome fatigue or exhaustion within 
the past two years. The separate specifications of exhaustion were compared to assess the role of 
shared criteria in the overlap of biological syndrome frailty and depression. Weakness was 
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assessed using the average of two measurements of dominant hand grip strength as measured by 
dynamometer. Weakness was defined as strength below BMI- and gender-specific thresholds 
established in the CHS. Slowness was defined as having a walking speed measured over a 2.5-
meter distance below gender- and height-specific cut-points established in the CHS (49). 
Participants were considered as meeting criteria for weakness or slowness if they attempted the 
corresponding physical measures but were unable to complete due to physical limitation. 
Participants who did not attempt physical measures due to lack of appropriate facilities or 
equipment or recent surgery were considered as missing on these physical measures. 
Frailty Index  
 As originally conceived, the Medical Burdens Frailty Index (FI) is a count of 70 clinical 
deficits, including presence of diseases, difficulties in daily activities, and other physical and 
neurological signs and symptoms (72). A FI score is calculated as the ratio of present deficits to 
total possible deficits (e.g. FI = 20/70 = .29). Subsequent analyses have demonstrated that frailty 
indices composed of 30 – 40 deficits have comparable predictive validity to the full index when 
deficits are selected based on pre-determined criteria (80, 81). Selection criteria for deficit 
inclusion are: 1) a deficit must generally accumulate with age, 2) a deficit must be related to 
health status in a biologically plausible way, 3) a deficit must not become saturated (i.e. 
universally prevalent) at an early age, and 4) the deficits together must represent a range of 
bodily systems (80). Using variables available in the HRS, the current study reproduced 35 of the 
original 70 deficits satisfying these selection criteria (Appendix 3.1). Although presence of 
depression may itself be considered an indicator in the FI, self-reported and study-determined 
depression diagnosis was excluded as an indicator in this study in order to address key study 
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questions of syndrome correlation. Each deficit was considered as either present (1) or absent (0) 
and no variable contained more than 5% missing cases within the analytic sample.  
Functional domains 
 Strawbridge and colleagues define frailty as functional impairment in at least two of four 
domains: physical, nutritive, cognitive and sensory (24). In the current study, impairment in each 
domain was designated as present (1) or absent (0) according to operational criteria defined by 
Cigolle and colleagues using HRS data (48). Impairment in physical functioning was defined as 
having persistent dizziness or lightheadedness, experiencing at least one fall in the prior two 
years, or having difficulty lifting or carrying weights over 10 pounds. Impairment in nutritive 
functioning was defined as a loss of 10% or more in BMI since the previous (2008) wave or a 
current BMI <18.5 kg/m2. Cognitive functioning was assessed using a 35-point composite 
measure of mental status, reasoning and memory task performance developed in the HRS (62, 
82). Impairment in cognitive functioning was defined as a score of 10 or less (corresponding 
with lowest 10% of HRS respondents) on the HRS cognitive performance measure. Sensory 
impairment was defined as having fair/poor self-rated vision despite use of corrective lenses or 
fair/poor hearing despite use of a hearing aid.   
Depressive Symptoms 
 Current depressive symptoms (referred to hereafter as “depression”) were measured using 
the 8-item Center for Epidemiological Studies–Depression scale (CESD) (59). Respondents are 
asked to indicate whether they have experienced any of the following symptoms much of the 
time during the previous week: 1) felt depressed, 2) felt activities were efforts, 3) had restless 
sleep, 4) felt happy, 5) felt lonely, 6) enjoyed life, 7) felt sad, 8) felt unmotivated. Positive 
symptoms (i.e. feeling happy and enjoying life) were reverse-coded. Although the CESD is not 
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intended to be a diagnostic tool for major depression, it has been shown to have moderate 
agreement with the Composite International Diagnostic Interview (CIDI), a structured instrument 
for assessment of major depression (59, 60).  
Sociodemoographic Covariates 
 Other variables included in the analysis were sex (male=0; female=1), race (dummy 
variables for white, black, and other), years of education (12 or more years=0; fewer than 12 
years=1), primary health insurance provider (dummy variables indicating private, Medicare, and 
Medicaid insurance), marital status (dummy variables for currently married/partnered, 
separated/divorced/never married, and widowed), and household poverty-to-income ratio 
(0=above poverty threshold; below poverty threshold=1). Age was treated as a continuous 
variable or in 10-year categories (65-75 years, 75-85 years, and greater than 85 years).  
ANALYSIS 
First, exploratory factor analyses (EFA) were performed for each of the latent constructs 
(three frailty models: biological syndrome, medical burden frailty index, and functional domains, 
and depression) separately to determine whether the factors, as specified, represented uni-
dimensional constructs.   
Figure 3.1a – c illustrates the confirmatory factory analysis (CFA) models used to 
evaluate the correlations between depression and frailty. CFA is an appropriate method for 
assessing correlation between latent factors that are not directly observable and which are 
imperfectly measured by the presence of observable symptoms (83). In CFA, constraints are 
imposed a priori on the number of latent factors, the variables used to indicate the factors, and 
the relationships between variables in the model (83, 84). In CFA latent factors are conceived as 
dimensional traits, existing on a continuum rather than as categorical diagnoses. In the current 
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study, indicators of the latent frailty factor were determined by the dichotomous symptoms from 
each of the three models described above, while depression was indicated by items from the 
CESD. Two types of CFA model were fit to the data: 1) single-factor models in which a single 
latent factor was indicated by both frailty items and depression items from the CESD (Figure 
3.1a); 2) correlated two-factor models in which separate frailty and depression factors were each 
defined by their respective indicator variables (Figure 3.1b). In cases where frailty and 
depression share symptoms by definition (i.e., the symptom “exhaustion” in the biological 
syndrome model of frailty, as described above), indicator variables were allowed to cross-load 
on each factor (Figure 3.1c). Models allowing cross-factor loading were compared with models 
in which shared symptoms indicated only depression in order to evaluate the role of shared 
symptoms in the correlation between frailty and depression.  
The influence of sociodemographic characteristics on latent factors was estimated using 
multiple indicator, multiple cause (MIMIC) structural equation models. MIMIC models allow for 
estimation of the influence of covariate characteristics such as age, sex, and race on latent 
variables.  MIMIC models contain at least two components: 1) a measurement component 
relating the indicator symptoms to the latent variables of frailty and depression (equivalent to 
CFA models), and 2) a regression component, regressing latent variables on the covariates 
(Figure 3.2a). When the correlation between frailty and depression was high (that is > 0.60), 
correlated factor models were equivalently re-expressed as second-order factor models in which 
a higher order factor is postulated to explain the correlation between frailty and depression. 
MIMIC models were used in these cases to estimate the influence of covariate factors on the 
second-order ‘vulnerability’ factor, indicated by frailty and depression sub-factors (Figure 3.2b). 
Model Estimation 
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 Models were estimated using weighted least squares means and variance adjusted 
(WLSMV) and full-information maximum-likelihood (MLR) estimators as implemented in 
Mplus software for categorical variables. MLR estimation was used in models which included 
data from participants who were missing physical measures data, under a missing at random 
(MAR) assumption. Model fit was assessed using standard fit criteria: Comparative Fit Index 
(CFI), Tucker-Lewis Index (TLI), and root mean square error of approximation (RMSEA). As 
recommended in previous research, pre-specified values of CFI >.90, TLI >.90, and RMSEA 
<.06 were taken to indicate adequate model fit (85).  
 Analyses were performed using MPlus (Version 7) and all p-values refer to two-tailed 
tests.  
 
RESULTS 
Sample Characteristics 
 Figure 3.3 illustrates the selection of the analytic sample. A total of 22,034 respondents 
participated in the 2010 HRS wave of whom 10,938 were 65 or older at the time of interview and 
were considered eligible for the study; 1,211 respondents were excluded because they were 
interviewed by proxy or resided in a nursing home. Of the community-dwelling, non-proxy 
respondents, 4,035 were selected for and consented to enhanced face-to-face interviews and 
physical measures. The primary analytical sample was restricted to 3,453 respondents who 
completed or attempted physical measures tasks (grip strength and walking speed). Primary 
reasons for incomplete physical measures were absence of a suitable space for testing (N=137), 
recent surgery or health condition preventing testing (N=98), and respondent thinking the task 
would not be safe (N=128).  
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 Table 3.1 shows the demographic and health characteristics of the analytic sample. 
Participants with a self-reported history of depression were more likely to be female, white, to 
have a household income below the poverty threshold, and to be Medicaid beneficiaries. 
Participants with a history of depression were significantly more likely to be frail according to 
diagnostic criteria proposed by the original authors of each of the three frailty models. 
Comparing individuals with a history of depression to those without, the odds of being 
considered frail at the time of interview were approximately twice as high according to the 
biological syndrome and functional domains models. According to the medical burdens FI 
model, the odds of being frail at time of interview were approximately four times as high for 
those with a history of depression.  
CFA models of depression and frailty 
 CFA models of the individual latent frailty variables as uni-dimensional factors produced 
good fit to the data, with all model fit indices satisfying pre-specified criteria (Appendix 3.2). 
Results using only data from the analytic sample (N=3,453) were similar to those using data for 
individuals with missing data under MLR estimation (N=4,035), and so only results from the 
analytic sample are reported (data not shown 
 Results from CFA models of depression and the three models of frailty are shown in 
Table 3.2. When depression and frailty were conceived as a single latent factor (indicated by 
symptoms of both depression and frailty), the biological syndrome and functional domains 
definitions fit the data adequately, while the medical burdens frailty index fit the data poorly 
according to pre-specified model fit criteria. Correlated two-factor models provided better fit to 
the data than single factor models according to all three definitions; however, fit indices 
indicated poor fit overall for the medical burdens frailty index definition. Correlation between 
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frailty and depression latent variables was substantial for each of the three frailty definitions with 
correlations of 0.67 (95% CI: 0.63 - 0.71) for the biological syndrome, 0.61 (95% CI: 0.59 - 
0.63) for the frailty index, and .70 (95% CI: 0.66 - 0.74) for the functional domains definitions.  
Because the biological syndrome and medical burdens frailty index models share items 
with the CESD (i.e., exhaustion), a third set of CFA models was estimated allowing cross-
loading of items to indicate both frailty and depression factors. Allowing shared symptoms to 
cross-load on both frailty and depression significantly improved the fit of both models. 
Correlation between frailty and depression decreased in the shared-symptom models for the 
biological syndrome (from .67 to .43) and for the frailty index (from .61 to 56) definitions, 
suggesting that shared symptoms determine some, but not all of, the correlation between the 
constructs. 
MIMIC models 
 The size of correlations between depression and the three frailty models suggested that 
frailty and depression could be instead specified as sub-factors of a higher order “vulnerability” 
latent factor. To further explore the influence of sociodemographic covariates on the correlation 
between frailty and depression, MIMIC models were fit to estimate the influence of 
sociodemographic covariates on the hypothesized higher order latent factor. Regression 
coefficients from MIMIC models are displayed in Table 3.3. Compared to men, women had 
significantly higher average factor level for each of the three frailty definitions (Biologic 
Syndrome: β = 0.12, 95% Confidence Interval (CI) 0.09 – 0.15; Medical burdens: β = 0.17, 95% 
CI 0.13 – 0.20; Functional domains: β = 0.09, 95% CI 0.06 – 0.12). Likewise, older age, lower 
education, not being married, having a household income below the poverty threshold, and being 
a Medicaid beneficiary were associated with higher levels of the second order latent factors for 
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each frailty definition. The influence of coefficients on the higher order latent factor suggest that 
these covariates predict greater levels of frailty, depression, and comorbid disorder. No 
significant differences in factor level were found among different races or among widows.   
 
DISCUSSION 
 This study examined the correlation between frailty and depression using three 
conceptually distinct definitions of frailty and a latent variable approach. Regardless of 
definition, frailty was substantially associated with depression, with correlation coefficients 
ranging from 0.61 to 0.70 in two-factor models. When accounting for the influence of shared 
symptomology and covariate predictors of the latent variables, correlation remained substantial. 
These results suggested the existence of a second-order “vulnerability” factor which influences 
levels of both frailty and depression. Our findings provide evidence that frailty and depression, 
as commonly defined in epidemiologic research, are not only associated concepts, but may be 
expressions of a  shared underlying vulnerability construct. This underlying construct, which 
subsumes physiological, functional, and psychological aspects of vulnerability, provides a 
sensible organizational structure to explain the frequent comorbidity of frailty and depression in 
the population. 
 These findings should be interpreted in light of study strengths and limitations. First, the 
HRS is among the largest, most well-characterized samples of older adults in existence. Because 
of the breadth of this data source we were able to operationalize and compare multiple 
definitions of frailty. This study is among the first, to our knowledge, to investigate the 
association between depression and multiple models of frailty using a common data source. 
Consistency of results across multiple definitions of frailty indicates that our inferences 
 
 
43 
 
regarding the nature of the relationship between depression and frailty are analytically and 
conceptually robust. Also, we explicitly accounted for the measurement error inherent in the 
study of syndromes like depression and frailty using latent variable modeling. This approach is 
important in the analysis of the discriminant properties of frailty for which there is no consensus 
definition.   
 We also note study limitations. First, our operationalizations of frailty were approximate, 
but not exact replications, of the measurement schema proposed by their original developers. 
Although care was taken to reproduce the elements of each definition as closely as possible, the 
extent to which the indicators do not capture the intended construct may introduce error in the 
results. Nevertheless, these operationalizations of frailty have been successfully applied in past 
studies of frailty in the HRS and were found to be consistent with the original definitions (48). 
Second, the analytic sample was restricted to those who were selected for and completed 
physical measures. While the physical measures subsample was selected at random from the 
HRS population, missing data on these measures may introduce bias. However, we believe this 
bias is minimal because models estimated using ML which included all participants eligible for 
physical measures regardless of missing values (N=4,035) produced similar results to models 
using only the analytic sample. Lastly, the measure of depression used in this study, the CESD, is 
not designed to approximate clinician diagnosis of major depression but is, rather, a catalog of 
current depressive symptoms. The extent to which the CESD does not capture the underlying 
construct of depression may have biased the results of the study; however, the CESD is among 
the most widely used scales for the measurement of depressive symptoms in epidemiologic 
research, and therefore its association with frailty has significance for research. Furthermore, the 
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CESD has been shown to produce moderate diagnostic agreement with more structured 
instruments for the assessment of major depression such as the CIDI (59, 60).  
 This study provides valuable insights into the measurement and definition of frailty and 
helps to synthesize disconnected lines of research in gerontology and psychiatry. One key 
finding is that the strong correlation exhibited between frailty and depression is not unique to a 
single definition of frailty and cannot be fully explained by shared symptomology. Indeed, the 
functional domains model, which shares no symptoms with the CESD, was the most highly 
correlated with depression. While model comparisons indicate that frailty and depression are 
distinct syndromes, the consistency of the relationship between these two constructs suggests the 
possible role of shared underlying vulnerability processes in determining frailty, depression and 
their comorbidity. Consistent with this hypothesis, studies have suggested that vascular disease 
and vascular ageing are important predictors in the development of frailty, sarcopenia, and other 
geriatric syndromes (67, 86, 87). The plausibility of this hypothesis is supported by findings that 
angiotensin-converting enzyme inhibitors, medications typically used in the treatment of 
hypertension and congestive heart failure, may help to prevent or slow decline in physical 
function and muscle strength (9, 10). Likewise, cerebrovascular diseases, particularly those 
leading to subcortical ischemic lesions, are thought to cause or to facilitate the expression of 
depression in late life (88). The specific nature of the underlying vulnerability processes 
proposed in this study remains to be explored.  
We note that alternative explanations of comorbidity between depression and frailty can 
also not be excluded. For instance, frailty and depression may be related through causal 
mechanisms, or vascular depression may be a prodromal state of frailty (38). However, the 
hypothesized processes determining comorbidity of frailty and depression provide a target for 
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future research and serve to merge and organize evidence from studies of frailty and late-life 
depression.   
Although this comorbidity can be viewed as a methodological nuisance to be avoided or 
addressed in studies aimed at predicting disability and decline, the confluence of frailty and 
depression may have important clinical implications. For instance, recent studies have 
demonstrated that frail older adults with depression have higher risk of mortality than non-
depressed frail elders, suggesting that depression may exacerbate or hasten the development of 
frailty symptoms (45). Individuals with both frailty and depression may thus benefit from more 
comprehensive interventions that assess and target both frailty and depressive symptoms, for 
instance, by combining anti-depressant treatment with exercise and nutritional interventions (45). 
Likewise, frailty status may be an important consideration in choosing between treatment options 
for depression, as some therapies may increase risk of falls among vulnerable older adults.   
In conclusion, our results demonstrated a significant and consistent correlation between frailty 
and depression among older adults, which is not be fully explained by definitional differences, 
symptom overlap, or sociodemographic covariates. Given that comorbidity of physical and 
mental disorders is common in late life, future research should continue to explore reasons for 
comorbidity and the combined implications of frailty and depression in predicting adverse health 
outcomes among older adults. 
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Table 3.1. Sample characteristics by lifetime history of depression    
 
Overall  
Lifetime 
Depression  
No 
Lifetime 
Depression   
 (n=3,453) (n=462) (n=2,991) p-Value 
  % or Mean (sd)   
Demographics        
Age (yrs) 75.0 (6.8) 73.5 (6.5) 75.2 (6.8) <.001 
Female 56.2 72.9 53.6 <.001 
Race    0.051 
White  84.7 88.3 84.1  
Black  11.9 8.7 12.4  
Other 3.4 3.0 3.4  
     
Education (>12 yrs) 43.7 42.2 43.9 0.512 
Household Poverty  7.6 10.4 7.1 0.018 
Marital Status    <.001 
Married/partnered 64.1 52.0 66.0  
Separated/divorced 11.6 15.4 11.1  
Widowed 24.3 32.7 23.0  
Health Insurance     
Medicare 96.8 97.4 96.7 0.568 
Medicaid 6.0 9.2 5.5 0.004 
Private 24.7 22.2 25.1 0.182 
Frailty      
Biological syndrome1 
    
Frail 11.7 20.8 10.3 <.001 
Intermediate 53.2 58.7 52.4  
Frailty Index2     
Frail 25.4 51.7 21.3 <.001 
Intermediate 27.7 27.3 27.7  
Funtional domains3 
    
Frail 22.2 35.7 20.4 <.001 
Intermediate 38.3 42.0 37.7  
          
1 Biological syndrome: frail = 3 or more symptoms; intermediate = 1 or 2 
symptoms 
2 Frailty index: frail = index score >.25; intermediate = index score >.15  
3 Functional domains: frail = 2 or more symptoms; intermediate = 1 symptom 
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Table 3.2. Model fit statistics and latent variable correlations  
  Frailty definition 
  
Biological 
syndrome  
Frailty  
index 
Functional 
domains 
     
Frailty and depression as single factor   
CFI  0.950 0.836 0.957 
TLI  0.940 0.828 0.947 
RMSEA  0.054 0.051 0.055 
     
Frailty and depression as separate but correlated latent factors  
CFI   0.944 0.854 0.952 
TLI  0.959 0.909 0.962 
RMSEA  0.054 0.049 0.053 
     
Correlation w/depression 0.67 0.61 0.70 
95% CI (0.63 - 0.71)  (.59 - 0.63) (.66 - .74) 
     
Correlation accounting for shared symptoms   
CFI   0.980 0.933 --- 
TLI  0.974 0.929 --- 
RMSEA  0.038 0.041 --- 
     
Correlation w/depression 0.43 0.56 --- 
       95% CI   (0.37 - 0.49) (.54 - .58) --- 
1For the biological syndrome definition, shared symptoms were items for not feeling 
motivated and feeling activities were an effort from the CESD 
2For the frailty index, the shared symptom from the CESD was feeling depressed much of 
the time in the past week 
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Table 3.3. MIMIC model regression coefficients of covariate influence on second-order latent variables  
 Frailty definition 
 Biological syndrome  Frailty index Functional domains 
  Estimate 95% CI Estimate 95% CI Estimate 95% CI 
Characteristics       
Female 0.12 (0.09, 0.15) 0.17 (0.13, 0.20) 0.09 (0.06, 0.12) 
Age       
65-75 --- --- --- --- --- --- 
75-85 0.08 (0.05, 0.11) 0.15 (0.11, 0.19) 0.08 (0.05, 0.11) 
85 or greater 0.17 (0.12, 0.22) 0.39 (0.33, 0.45) 0.21 (0.16, 0.26) 
Race       
White --- --- --- --- --- --- 
Black -0.01 (-0.05, 0.03) -0.02 (-0.07, 0.03)  0.01 (-0.03, 0.04) 
Other 0.07 (-0.01, 0.14) 0.00 (-0.09, 0.09) 0.07 (-0.01, 0.15) 
Marital Status       
Married --- --- --- --- --- --- 
Separated/divorced 0.17 (0.12, .22) 0.19 (0.13, 0.25) 0.14 (0.10, 0.18) 
Widowed 0.01 (-0.04, 0.06) 0.01 (-0.05, 0.07) 0.02 (-0.02, 0.06) 
Education < 12 years 0.24 (0.20, 0.28) 0.32 (0.28, 0.36) 0.26 (0.22, 0.30) 
Income (below poverty 
threshold) 
0.13 (0.08, 0.18) 0.15 (0.11, 0.19) 0.16 (0.11, 0.21) 
Health Insurance       
Medicaid 0.20 (0.14, 0.26) 0.34 (0.28, 0.41) 0.19 (0.14, 0.24) 
Medicare  -0.01 (-0.09, 0.07) 0.05 (-0.05, 0.15) 0.00 (-0.07, 0.07) 
Private insurance -0.01 (-0.04, 0.03) -0.02 (-0.06, 0.03) -0.03 (-0.06, 0.01) 
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Figure 3.1a. Single latent factor model of frailty and depressive symptoms  
 
Symptoms of frailty and depression indicate a single latent factor implying that a single 
underlying condition explains variance among both frailty and depressive symptoms. 
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Figure 3.1b. Two-factor model without symptom overlap 
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Figure 3.1c. Two-factor model assuming shared symptoms and cross loading 
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Figure 3.2a. Example of MIMIC model adjusting for sociodemographic covariates 
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Figure 3.2b. Example of MIMIC model with second-order latent factor 
 
Note: Similar models were fit for each of three frailty definitions. Not all covariates included in analyses 
are depicted in figure.  
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Figure 3.3. Sample inclusion/exclusion flowchart 
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Chapter 4: Frailty, Adverse Health Outcomes and Influence of Depression: A 
Latent Growth Curve Analysis 
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ABSTRACT 
Objectives:  This study used latent growth curve modeling (LGCM) to estimate trajectories of 
frailty and association between frailty trajectories and propensity for nursing home admission 
and falls. The time-varying influence of depression on the association of frailty and adverse 
health outcomes was also evaluated. 
Methods: This study used data from five waves (2004-2012) of the Health and Retirement 
Study. A total of 10,611 community-dwelling individuals age 55 and older who participated in 
all waves were included in analysis. Frailty was measured using three alternative models: 1) 
functional domains, 2) medical burdens, and 3) biological syndrome. Depressive symptoms were 
measured using the 8-item Centers for Epidemiologic Studies Depression (CESD) scale. Adverse 
health outcomes included any nursing home stay within the previous two years and or injury 
from falls requiring medical treatment. Latent growth curves were used to estimate frailty 
trajectories and propensity to experience adverse health outcomes. 
Results: The proportion of participants considered frail increased over the study period, and 
LGC models showed that average frailty trajectories were positive for all three frailty definitions 
(Functional domains: β=.182, p<.001; Medical Burdens: β=.078, p<.001; Biological Syndrome: 
β=.375, p<.001). Socio-demographic characteristics predicting steeper growth differed based on 
frailty definition. Parallel growth process models showed that steeper increases in frailty were 
associated with higher likelihood of both nursing home admission and serious falls (Functional 
Domains: βNursingHome=.594, p<.001; βFall=1.759, p<.001; Medical Burdens: βNursingHome=.889, 
p<.001; βFall=1.782, p<.001; Biological Syndrome: βNursingHome=.333, p<.001; βFall=1.306, 
p<.001). However, these associations were attenuated, and in some cases were no longer 
statistically significant, after accounting for depressive symptoms.  
 
 
57 
 
Discussion: Developmental trajectories of frailty may be important indicators of risk for nursing 
home admissions and falls, independent of baseline frailty status. Targeted interventions focused 
on slowing development or progression of frailty symptoms may provide benefits in helping 
older adults maintain functional independence. Future studies of frailty must account for 
concurrent depression status as an important and highly correlated condition. 
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INTRODUCTION 
 Epidemiologic studies indicate that frailty, a syndrome purported to represent 
vulnerability to poor health outcomes, is common in late life. The likelihood of being frail 
increases with age, with 10% of adults age 65 and older and over 30% of adults age 85 and older 
considered frail (46). The prevalence of frailty varies considerably by sociodemographic 
characteristics. Women, racial minorities, and individuals with less education have higher risk of 
frailty (46, 89, 90). Epidemiologic evidence has linked frailty to higher risk of outcomes such as 
falls, nursing home entry, hospitalization, and earlier mortality (49, 72, 91). Frailty has also been 
used as a clinical measure to determine eligibility for treatment approaches such as surgery and 
pharmacologic intervention (11-14).  
Despite frequent use of frailty in epidemiologic and clinical research, there is no 
consensus regarding its operationalization. Various competing conceptual and operational 
models have emerged, yielding significantly different estimations of frailty (19, 48, 51, 92). At 
least three conceptually distinct models have been used extensively in research literature: 1) a 
biological syndrome model (49), 2) a medical burdens model (21), and 3) a functional domains 
model (24). The biological syndrome and medical burdens models are the two most widely cited 
and validated measures of frailty (26, 93); however, these three models offer conflicting views 
regarding the underlying nature of the frailty construct. Whereas the biological syndrome model 
conceives of frailty as a syndrome of five specific physiological symptoms, distinct from the 
concept of comorbidity (18, 50), the medical burdens model posits that frailty is indexed as a 
sum of accumulated disorders and deficits, similar to comorbidity (17, 81). While the functional 
domains model is cited less frequently in the research literature, its focus on frailty as measured 
by functional limitations provides a third distinct conceptual basis for measuring frailty (26). To 
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varying degrees, each of the three frailty models has been validated in terms of their ability to 
predict adverse health outcomes; however, few studies have compared the longitudinal 
relationship of all three models to such outcomes (16, 21, 24, 49). 
An important consideration in the study of frailty is its relationship to late-life depression. 
Evidence from multiple fields suggests that frailty and depression are highly related, both as 
comorbid conditions and as conceptually similar conditions (32, 33, 38, 42, 45). First, frailty and 
depression share symptoms (i.e., weight loss, fatigue) and increase risk of similar adverse health 
outcomes over time. For instance, both frailty and depression have been found to increase risk of 
earlier mortality among older adults (49, 91, 94, 95). Second, common instruments used for case 
ascertainment of frailty and depression lead to similar categorization of afflicted individuals. For 
instance, previous work by our group has shown that operationalizations of frailty and depression 
produce highly concordant estimates of individuals who are frail and depressed (40, 75). Lohman 
et al. (Chapter 3) further showed that, when modeled as dimensional traits, depression and frailty 
were substantially correlated after adjusting for sociodemographic covariates related to 
prevalence of both conditions. Third, depression among older adults is often characterized by a 
relative lack of mood symptoms and greater number of neurovegetative symptoms, in what has 
been termed “depression without sadness” or “masked depression” (41, 96, 97). This alternate 
presentation of depression among older adults may lead to further difficulties in discriminating 
depression from frailty in late life. The substantial comorbidity and common symptomology 
between frailty and depression indicate the need for approaches which incorporate rather than 
exclude depression as a consideration in studies of frailty.  
 Frailty, like depression, is a dynamic condition in which symptoms may manifest and 
remit over time (98). Accordingly, the risk of poor health outcomes conferred by frailty likely 
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also changes over time. Despite this, research on frailty rarely accounts for temporal changes in 
frailty status, instead focusing on whether an individual is categorized as frail or not frail at a 
given point in time and whether this status predicts future outcomes (19, 21, 24, 47, 49). Failure 
to account for temporal changes and dynamic nature of frailty may lead to incorrect inferences 
about the frailty construct and its relationship with poor health. 
There are two primary aims of the current study. First, we will use latent growth curve 
models to estimate the trajectories of frailty using the three definitions (biological syndrome, 
medical burdens, and functional domains) outlined above. We will assess whether these frailty 
growth trajectories are associated with two adverse outcomes in later life: likelihood of nursing 
home admission and likelihood of falling. Although previous research has linked baseline frailty 
status with risk of future adverse health outcomes, to date none have assessed whether 
trajectories of frailty are associated with the likelihood of experiencing adverse health events. As 
part of this aim, conditional latent growth models will be used to determine whether frailty 
trajectories are influenced by characteristics such as gender, race, and education. The second aim 
is to determine the extent to which depression, treated as a time-varying covariate, influences the 
relationship between frailty and adverse health outcomes. We expect that, given the strong 
association between frailty and depression indicated by prior research, incorporation of 
depression will substantially diminish the relationship between frailty and adverse health 
outcomes.  
METHODS 
 Data for the current investigation come from the Health and Retirement Study (HRS), an 
ongoing household survey initiated in 1992 in order to study the health and financial dynamics of 
older Americans. The HRS is a multi-stage area probability sample of household units designed 
 
 
61 
 
to be representative of the non-institutionalized U.S. population of adults over the age of 50 (57). 
New cohorts of participants are added every three waves (six years) in order to maintain the 
steady-state and representativeness of the sample. The latest wave of interviews was completed 
in 2012. The primary HRS questionnaire is administered by telephone at study entry and at 
subsequent two-year intervals. The questionnaire asks respondents to report information 
regarding demographics, health conditions, functional limitations, health insurance and other 
determinants of health. Beginning in 2004, a random half-sample of HRS respondents was asked 
to complete an enhanced face-to-face interview including objective physical measurements of 
gait speed, strength, balance and other aspects of physical health (58). The enhanced face-to-face 
interview was completed on the remaining half of the sample in alternate years.  
The 2004 HRS wave had 19,750 respondents, of whom 66% (N=13,054) remained in the 
study as of the 2012 wave. Respondents were selected for this analysis if they met several 
selection criteria: first, participants were included in analysis if they were at least 55 years of age 
in 2004 ensuring that all study participants would be 65 years or older during the last interview 
wave. Since nursing home stay was a primary outcome of interest, participants were excluded 
from analysis if they resided in a nursing home at the time of study entry (n=93) or if they were 
interviewed via a proxy respondent (n=625). These selection criteria resulted in a final analytic 
sample of N=10,611 respondents. Information for these respondents from waves 2004, 2006, 
2008, 2010, and 2012 was used in the current study. 
The HRS is approved by the Institutional Review Board (IRB) at the University of 
Michigan, and this analysis received exempt status from the IRB at Virginia Commonwealth 
University. All participants provided informed consent. 
MEASURES  
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Frailty 
Biological Syndrome 
 Fried and colleagues define frailty as a biological syndrome represented by five specific 
symptoms derived from the Cardiovascular Health Study (CHS): slow gait speed, muscle 
weakness, low physical activity, exhaustion, and low of body weight (49). In the current study, 
gait speed was measured by time to complete a 2.5-meter walking course and stratified by sex 
and height. Slowness was defined according to sex- and height- specific cutoff values proposed 
in the CHS (Appendix 4.1). Strength was defined as the average of two grip-strength 
measurements of the respondent’s dominant hand by dynamometer. Weakness was defined as 
grip strength below gender- and BMI- specific thresholds established in the CHS (Appendix 4.1). 
Participants were considered as meeting criteria for weakness or slowness if they attempted the 
corresponding physical measures but were unable to complete due to physical limitation. 
Physical activity was measured as the average frequency of self-reported mild, moderate, and 
vigorous activity weighted according to metabolic equivalency of task (MET) scores (Appendix 
4.1). Participants in the lowest 20% of physical activity were considered to have low physical 
activity. Exhaustion was defined as self-reported persistent or troublesome fatigue or exhaustion 
within the past two years. Low weight was defined as a loss of 10% or more in BMI in the past 
two years or a current BMI < 18.5 kg/m2. Participants were considered frail according to the 
biological syndrome model if they endorsed or exhibited at least three of the symptoms described 
above and intermediately frail if they endorsed one or two symptoms (49).  
Medical Burdens  
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 The medical burdens model, conceived by Rockwood and colleagues, defines frailty as 
an accumulated burden of diseases, functional disabilities and other health-related deficits and 
symptoms. The primary metric used to determine presence of frailty in the medical burdens 
model, the frailty index (FI), is calculated as the ratio of present deficits to the number of total 
possible deficits considered in the study (e.g. FI=10/30=.33). The medical burdens model is 
designed to provide a flexible measure of frailty that may be utilized and compared across 
multiple surveys (17, 80). Therefore, the deficits included in the FI calculation are non-specific 
provided they satisfy certain inclusion criteria: 1) a deficit must accumulate with age, 2) a deficit 
must not become universally prevalent at an early age (e.g. presbyopia), 3) a deficit must be 
related to health status in a biologically plausible way, and 4) the deficits considered together 
must represent a range of bodily systems, and 5) the deficits making up a FI must be consistent 
across time (80). While there is no maximum or minimum number of deficits which may be 
included in a FI, prior studies suggest that frailty indices composed of 30 to 40 deficits have 
sufficient specificity to predict adverse health outcomes (17, 80). The current study used a FI 
consisting of 30 deficits satisfying the inclusion criteria outlined here (Appendix 4.2). Frailty 
status was determined using cutoff criteria established in prior studies: participants with a FI 
score > 0.25 were considered to be frail while those with a score between 0.15 and .25 were 
considered intermediately frail (21, 48).  
Functional domains 
 Strawbridge and colleagues define frailty as functional impairment in at least two of four 
domains: physical, nutritive, cognitive, and sensory (24). Consistent with prior 
operationalizations of this model, participants were considered to have impairment in physical 
functioning if they reported persistent dizziness or lightheadedness, experienced at least one fall 
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within the past two years, or have difficulty lifting or carrying weights over 10 pounds. 
Impairment in nutritive functioning was defined as a loss of 10% or more in BMI since the 
previous (2008) wave or a current BMI <18.5 kg/m2. Cognitive functioning was assessed using a 
35-point composite measure of mental status, reasoning and memory task performance 
developed in the HRS (62, 82). Cognitive impairment was defined as a score of 10 or less on the 
HRS cognitive performance measure. Sensory impairment was defined as having fair/poor self-
rated vision despite use of corrective lenses or fair/poor hearing despite use of a hearing aid.  
Participants with impairment in at least two domains were considered frail whereas participants 
with impairment in a single domain were considered intermediately frail.  
Depressive Symptoms 
 Depressive symptoms were indexed using the 8-item Center for Epidemiological Studies 
– Depression scale (CESD) (59). The CESD asks respondents to report whether they experienced 
eight symptoms much of the time during the past week: 1) felt depressed 2) felt activities were 
efforts, 3) had restless sleep, 4) felt happy, 5) felt lonely, 6) enjoyed life, 7) felt sad, 8) felt 
unmotivated (could not get going).  Positive symptoms of feeling happy and enjoying life were 
reverse-coded, so that their absence indicated a depressive symptom. The CESD is not a 
structured interview meant to emulate clinician diagnosis of major depression; however, prior 
studies have shown that when used as a diagnostic substitute (using a cutoff of four or more 
symptoms to indicate depression), the CESD has moderate agreement with structured diagnostic 
instruments such as the Composite International Diagnostic Interview (CIDI) (59, 60). In the 
current study, participants who endorsed four or more symptoms were considered to be 
depressed. Depression was assessed using a dichotomous variable (1=depressed, 0=not 
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depressed) at each wave of the HRS, allowing the presence of depression for individuals to vary 
over time.  
Outcome Measures 
 The current study considered frailty trajectories in relation to two adverse health 
outcomes: nursing home admission and serious falls. Nursing home admission was assessed 
using a dichotomous variable (1=any nursing home stay, 0=no nursing home stay) indicating 
whether a respondent had been a patient overnight in a nursing home, convalescent home, or 
other long-term health care facility in the preceding two years. This variable encompassed both 
short stays (e.g., for rehabilitation after a hospital discharge) as well as longer stays. Analysis 
was repeated considering only those respondents whose nursing home stays were longer than 30 
days as experiencing a nursing home stay. We considered ‘serious falls’ as any fall within the 
past two years which resulted in injury requiring medical treatment as reported by the 
respondent. Respondents who experienced a fall which did not result in injury were considered 
not to have experienced a serious fall. A dichotomous variable (1=experienced a serious fall, 
0=did not experience a serious fall) was used in analysis.  
Time-invariant Covariates 
 Sociodemographic characteristics and other health related variables were chosen for 
inclusion as time-invariant covariates in analysis through a forward selection change-in-estimate 
procedure: First, bivariate logistic regression of frailty status and each of the adverse health 
outcomes (nursing home stays, falls) at baseline were fit; second, covariates were added 
individually to the logistic regression and variables producing the largest change in estimate of 
the frailty/outcome relationship were included as potential confounders; third, addition of 
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covariates to the logistic regression continued until individual covariates no longer produced a 
substantial change in estimate (> 10%) (99).  
 Based on the change-in-estimate selection procedure, time-invariant covariates 
considered in analysis were sex (male=0; female=1), race (dummy variables for white, black, 
and other), years of education (12 or more years=0; fewer than 12 years=1), primary health 
insurance provider (dummy variables indicating private, Medicare, and Medicaid insurance), 
marital status (dummy variables for currently married/partnered, separated/divorced/never 
married, and widowed), smoking status (1=current smoker, 0=not current smoker), and 
household poverty-to-income ratio (0=above poverty threshold; below poverty threshold=1). 
Age was assessed in 10-year categories (65-75 years, 75-85 years, and greater than 85 years).   
ANALYSIS 
 Growth of frailty and adverse health outcomes over time was modeled using latent 
growth curve modeling (LGCM). LGCM is a statistical procedure built on confirmatory factor 
analysis (CFA) approaches (83) used to estimate underlying latent (unobserved) growth 
parameters that give rise to estimates and interrelations among a set of observed repeated 
measures. In a LGCM framework, the growth parameters are used to describe average latent 
linear or non-linear trajectories of change over time, as well as individual variability in those 
growth trajectories (100). LGCM is an appropriate approach to for modeling longitudinal change 
for four reasons: 1) it allows for tests of overall model fit, 2) it allows for regression of intercept 
and slope estimates on other explanatory variables and growth parameters while accounting for 
imperfect measurement, 3) it can be used to model growth in categorical observed measures, and 
4) it allows straightforward incorporation of time-varying explanatory covariates (100). More 
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detailed discussions of the theoretical and mathematical bases of LGCM are available elsewhere 
(100). 
Unconditional and Conditional Latent Growth Models  
In the current study, LGC models were built in a hierarchy of increasing complexity. 
First, unconditional models of each of the three frailty models and two primary outcomes were 
fit to assess overall growth in these constructs over time, unadjusted for influence of covariates. 
Two types of growth, linear and quadratic, were modeled for each outcome and compared in 
terms of overall model fit and parsimony. Linear growth was specified by constraining the 
loadings of the latent growth parameters on the observed outcomes to assume incremental 
change per increase in unit time (Figure 4.1). That is, the factor loading for slope was fixed to 0 
for Wave 1 frailty status, to 1 for Wave 2 frailty status, to 2 for Wave 3 frailty status, and so on. 
Quadratic growth was modeled by the addition of a quadratic latent growth parameter and by 
fixing factor loadings of the quadratic term to assume exponential change. Because outcomes 
were modeled as dichotomous variables, the growth factors were interpreted as describing the 
change in underlying latent propensity of the outcome under a continuous threshold model. That 
is, increasing levels of latent propensity toward frailty predict the likelihood of reaching a 
threshold distinguishing frail and not frail individuals. 
Time-invariant covariates were subsequently added to the unconditional models to assess 
influence of these variables on the growth parameters (Figure 4.2). The growth parameters 
represent continuous variables, and thus estimates were interpreted as linear regression 
coefficients explaining the change in growth parameter (e.g. intercept), associated with each 
change in unit of the covariate. Growth parameters and model fit statistics from conditional 
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models were compared with those from unconditional models to assess influence and 
explanatory significance of the covariates.  
Parallel Process Models and Time-varying Depression 
 Building on conditional growth models, the next set of models addressed the relationship 
between trajectories of frailty and change in the propensity to experience adverse health 
outcomes. In these models, two growth processes (e.g. growth of frailty and expected change in 
the propensity to be admitted to a nursing home stay), were related through the regression 
(correlation) of their growth parameters (Figure 4.3). The intercept (initial level) and the slope of 
change of each adverse health outcome propensity were regressed on the intercept and slope of 
change in frailty for each of the frailty models. The growth parameters for each process were 
conditioned upon the time-invariant covariates introduced in preceding models.  
 Next, to address the secondary aim of the current study, depression status was introduced 
into the parallel process models as a time-varying predictor of frailty at each corresponding 
wave. Relationships between the dichotomous variables of depression and frailty were estimated 
in terms of log odds of being frail comparing depressed and non-depressed respondents. The 
influence of frailty growth parameters on growth parameters of adverse health outcomes were re-
estimated and compared to estimates unadjusted for depression status. 
Model estimation and fit criteria   
 All LGCMs were estimated using maximum likelihood and weighted least squares means 
and variance adjusted (WLSMV) estimation as implemented in Mplus software version 7 
(Muthén & Muthén, Los Angeles, CA). Model fit was assessed using standard fit criteria: 
Comparative Fit Index (CFI), Tucker-Lewis Index (TLI), and root mean square error of 
 
 
69 
 
approximation (RMSEA). Values of CFI >.95, TLI >.95, and RMSEA <.05 were taken to 
indicate close model fit to the data (85). All p-values refer to two-tailed tests. 
 
RESULTS 
 At the 2004 HRS interview (baseline for this analysis), all 10,611 respondents in the 
analytic sample were between 55 to 95 years old. Approximately 61% were female, 84% white, 
and 70% were married, with a range of other sociodemographic and health related characteristics 
described in Table 4.1. The three frailty models produced substantially different estimates of the 
number of frail individuals in the sample at baseline, ranging from approximately 8.4% 
according to the biological syndrome model to 27.4% according to the medical burdens model. 
The characteristics of frail older adults for each definition were similar (Table 4.1): frail 
respondents were older and were more likely to be female, had less education, were more likely 
to be widowed or divorced/separated, and were more likely to have a household income below 
the poverty threshold. Notably, the functional domains model identified a higher proportion of 
black respondents as frail compared to the other two definitions (21.4% vs. 14.4% for the 
biological syndrome and 16.0% for the medical burdens models). The proportion of frail older 
adults in the sample increased over the study period for all frailty definition (Table 4.2). In the 
final wave of analysis, the point prevalence of frailty was approximately 44% according to the 
medical burdens model, 34% according to the functional domains model, and approximately 
21% according to the biological syndrome model.  
Unconditional Latent Growth Models 
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 Parameter estimates from unconditional latent growth models of frailty and risk of 
nursing home entry or falls are displayed in Table 4.3. Compared to linear growth models, 
quadratic growth models did not provide significantly better model fit for any of the frailty 
definitions or adverse health outcomes, and so only results from linear growth models are 
hereafter reported (data not shown). As shown in Table 4.3, the mean slope of frailty propensity 
was significantly positive for each of the three frailty definitions over time (Functional Domains: 
β=.182, p<.001; Medical Burdens: β=.078, p<.00; Biological Syndrome: β=.375, p=.01), 
reflecting an increasing expected likelihood of being considered frail over the study period. The 
variances of each of the frailty intercept and slope parameters were also statistically significant, 
suggesting that there is significant variability in initial level of frailty and in the change of frailty 
propensity between individuals over time. As seen in Figures 4.5-4.7, model estimated 
probabilities of frailty accurately predicted the observed sample proportions of frailty in the 
study population and model fit criteria reflect close model fit for each definition. This indicates 
that the specified linear growth model is appropriate for describing change of frailty over time.  
The mean and variance of slope for nursing home stay was not significantly different 
from zero, suggesting that, unconditioned on predictors, the propensity of needing a nursing 
home stay did not increase or decrease over time and was not significantly different among 
individuals. The slope of change for experiencing a serious fall was also not significantly 
different from zero and moderately negative, suggesting that the mean likelihood of experiencing 
a serious fall did not change over time. 
Conditional Latent Growth Curve Models 
 Parameter estimates and covariate regressions from conditional growth models of frailty 
are displayed in Tables 4.4 and 4.5. Model fit improved moderately with the addition of 
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explanatory covariates according to RMSEA and remained similar according to CFI and TLI. 
Slope and intercept growth factors remained significantly greater than zero, suggesting that even 
after adjusting for the influence of time-invariant covariates, the mean likelihood of frailty 
increased over the study period. Similarly, the significant variances of slope and intercept for 
each frailty definition suggest that there was significant heterogeneity in trajectories of frailty 
over time not explained by these fixed characteristics. Regression of intercept growth parameters 
on covariates indicated that being female, divorced, having less education, being a current 
smoker, and having low income were significantly associated with higher baseline levels of 
frailty. Each 10 year increase in age above 55 was also associated with higher initial levels of 
frailty. While initial level of functional domains frailty was significantly greater among widows 
and among black and other race participants (compared to whites), widowhood and race were not 
significantly associated with baseline levels of frailty according to the other definitions.  
 Regressions of slope parameters on time-invariant covariates revealed further differences 
in growth of frailty according to the three definitions. Being female, divorced, and of black race 
was associated with increasing frailty over time according to the biological syndrome model 
only. Whereas lower educational attainment and income were associated with higher initial 
levels of medical burdens frailty, these characteristics did not have significant influence on rate 
of change in medical burdens frailty over time. Older age and current smoking were associated 
with higher rates of growth in all three definitions of frailty. Results from conditional growth 
models of adverse health outcomes are presented in Appendix 4.3-4.4.  
Parallel Process Models 
 Further analysis explored the association between frailty growth and the propensity to 
experience adverse health outcomes. Table 4.6 details the results from regressions and 
 
 
72 
 
covariances relating the growth parameters of each frailty definition with growth parameters for 
nursing home stay for models both unadjusted and adjusted for depression. Not accounting for 
the influence of depression, initial level of frailty was correlated with greater baseline likelihood 
of requiring a nursing home stay for all frailty definitions. Initial level of frailty was not, 
however, directly related to change in nursing home propensity over time. For all frailty 
definitions, greater slope of change for frailty was associated with greater slope in nursing home 
probability (Functional Domains: β=.594, p<.001; Medical Burdens: β=.771, p<.001; Biological 
Syndrome: β=.333, p<.001), suggesting that growth in frailty was significantly associated with 
propensity to needing nursing home care. That is, higher rates of frailty change were 
significantly associated with more rapid increase in the likelihood of experiencing nursing home 
admission. 
 When depression status was incorporated into parallel process models as a time-varying 
covariate, concurrent depression was a significant predictor of frailty at each wave and for each 
frailty definition. Participants with depression had on average between 50% and 140% higher 
odds of frailty depending on the wave and definition of frailty, as seen in Table 4.6. The 
inclusion of depression into parallel process models also significantly changed estimates of 
associations between growth parameters. Regression coefficients describing the relationship 
between frailty slope and slope in nursing home propensity were diminished and non-significant 
after accounting for depression (Functional Domains: βconditional on time-invariant covariates= 0.594, 
p<.001 vs. βaccounting for time-varying depression=0.476, p=.857; Medical Burdens: βconditional on time-invariant 
covariates= 0.889, p<.001 vs. βaccounting for time-varying depression=0.771, p=.853; Biological Syndrome: 
βconditional on time-invariant covariates= 0.333, p<.001 vs. βaccounting for time-varying depression=0.251, p=.832), 
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suggesting that depression status explained a significant portion of the variation in nursing home 
propensity over time.  
 Parallel process models with serious falls as the adverse health outcome are displayed in 
Table 4.7. Unlike nursing home stay, initial frailty level (intercept) was significantly associated 
with both initial propensity for experiencing a serious fall and higher rate of change in this 
propensity over time (Functional Domains: β=1.759, p<.001; Medical Burdens: β=1.782, p<.001; 
Biological Syndrome: β=1.306, p<.001). As with nursing home stays, addition of depression as a 
time-varying covariate reduced the association between frailty slope and slope of propensity for 
fall; however, these estimates remained significant depression (Functional Domains: βconditional on 
time-invariant covariates= 1.759, p<.001 vs. βaccounting for time-varying depression=1.193, p=.001; Medical 
Burdens: βconditional on time-invariant covariates= 1.782, p<.001 vs. βaccounting for time-varying depression=1.366, 
p<.001; Biological Syndrome: βconditional on time-invariant covariates= 1.306, p<.001 vs. βaccounting for time-
varying depression=0.977, p=.001) 
 
DISCUSSION 
 There were two primary aims to the current study. First, we used LGCM to model frailty 
change over time and to assess whether both initial level of frailty and change in frailty over time 
was associated with experience of adverse health outcomes using three competing definitions of 
frailty. We accounted for the influence of time-invariant covariates on frailty trajectories using 
conditional LGCM. The second aim was to evaluate the influence of depression as a time-
varying covariate on the relationship between frailty and adverse health outcomes. Our results 
indicate that, regardless of the operationalization of frailty employed, the predictive relationship 
between frailty and risk of nursing home entry and serious falls is substantially reduced (and in 
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the case of nursing home admission, essentially null) after accounting for depression status. 
Results of these aims provide valuable insights into the dynamic nature of frailty syndrome in 
later life and its relationship with depressive symptoms.  
Frailty growth and adverse health outcomes 
Building on prior frailty research, analysis showed that frailty is a dynamic condition and 
that the influence of this condition on adverse health outcomes extends beyond frailty status at a 
single time-point. Unconditional LGCM showed that, on average, the expected level of frailty 
increased over the study period and that there was significant inter-individual variability in both 
the initial level and rate of change of frailty over time. Regardless of the conceptual basis and 
operationalization of frailty, the probability of being frail approximately doubled over the study 
period. This finding highlights the importance of modeling initial frailty status in conjunction 
with change in frailty status over time, as our findings indicate that both have independent 
relationships with adverse health outcomes over time. Indeed, parallel process models showed 
that greater rates of change in frailty were significantly associated with more rapid increase in 
the likelihood of experiencing serious falls as well as nursing home admission. The reliability of 
these findings across multiple definitions of frailty indicates that frailty development is an 
important consideration which is not reserved for any particular conceptual orientation.   
These results supplement what is currently known about frailty and its development over 
the life course. While there is an implicit acknowledgement that the signs of frailty may arise 
over long periods of time (54), few studies have incorporated frailty change explicitly in 
analysis. Many studies have assessed the role of frailty as a static predictor of poor health (21, 
49), but the current results extend this research by providing evidence that developmental 
trajectories of frailty are themselves important predictors of poor outcomes. The distinction 
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between baseline frailty and frailty trajectories is valuable as it may lead to more refined 
identification of vulnerable older adults. The more rapid accumulation of frailty symptoms and 
indicators over time may signal increased vulnerability to poor health outcomes and higher 
health service utilization, even among individuals who would not meet standard criteria for 
frailty. Future research in frailty would benefit from focus on trajectories of frailty symptom 
accumulation, as slowing the progression of frailty symptoms might provide therapeutic targets 
independent of frailty status.  
Predictors of frailty levels and trajectories 
The time-invariant conditional LGCM of frailty provide further insights into potentially 
important differences between competing definitions of this syndrome. For example, more 
education and higher income were associated with lower initial probability and lower rate of 
change in frailty for the functional domains and biological syndrome definitions, consistent with 
literature on social disparities in disability (101, 102). However, these factors did not 
significantly influence change in medical burdens frailty over time. This difference might reflect 
the medical burden definition’s emphasis on chronic disease states which may be less malleable 
to the influence of compensatory resources (e.g. education and wealth) over time. Likewise, 
female gender was significantly associated with rate of change of frailty only according to the 
biological syndrome definition. A potential explanation for this difference is that the biological 
syndrome definition emphasizes sarcopenia and muscle weakness which may be more common 
among women (19, 47). Taken together, these findings are in accordance with prior research 
demonstrating marked differences in the identification of frail individuals produced by 
competing definitions (48). This study builds on this research by showing that competing frailty 
definitions may also lead to different conclusions about the factors and characteristics which 
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determine the presence of and predict the development of frailty. The choice of frailty definition 
can therefore have considerable impact on how frailty is studied and treated, and who is 
considered “high risk.”  
The longitudinal relationship between frailty and depression 
 These results provide evidence for the hypothesis that frailty and depression are two 
highly interrelated conditions in late-life. When depression status was introduced into models as 
a time-varying covariate, the association between frailty and serious falls was substantially 
diminished and the association with nursing home entry became non-significant. This indicates 
that depression status and frailty status explain much of the same variation in determining which 
individuals experience adverse health outcomes over time. There are a number of potential 
explanations for these findings. One possibility is that frailty and depression independently lead 
to similar poor health outcomes. While frailty and depression are both associated with poor 
health (49, 94), it is unlikely, given their pervasive comorbidity and established diagnostic 
overlap (40, 75), that they are wholly independent of one another. A more likely explanation is 
that frailty and depression are comparable, but distinct, expressions of a more general underlying 
process of physiological and psychosocial decline. For example, age-associated cardiovascular 
changes play a role in development of both frailty and depression (67, 86-88), and may help to 
explain comorbidity and common consequences of the two conditions. Consistent with this 
hypothesis, Hajjar and colleagues have identified an age-related phenotype characterized by 
depressive symptoms and features of frailty such as slow gait speed and poor executive 
functioning (67); hypertension, diabetes and other cardiovascular disorders were independently 
associated with this phenotype (67).   
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 Other explanations, for instance that depression is a cause of or prodromal state of frailty 
(38), cannot be discounted based on the current analysis. Nonetheless, findings regarding the 
joint influence of frailty and depression on poor health outcomes signal the need for more 
comprehensive investigations of geriatric syndromes like frailty. Incorporating, rather than 
excluding, depression as a primary measure in frailty research will help to merge two separate 
lines of investigation from frailty and late-life depression. Joint consideration of frailty and 
depression may also help to identify older adults at higher risk and to tailor treatment to address 
both physiological and psychosocial vulnerabilities (45). 
 The primary strength of this study lies in the use of LGCM in a population-based sample. 
To our knowledge, this is among the first applications of LGCM to understanding change in 
frailty over time. LGCM allows us to address the question of whether frailty trajectories are 
associated with poor health outcomes independently of baseline frailty status and allows 
straightforward inclusion of time-varying covariates in analysis. Furthermore, the robustness of 
the findings is strengthened by replication across multiple definitions of frailty and multiple 
adverse health outcomes. Comprehensive analysis is possible because of the extensive collection 
of longitudinal health information and large sample size available in the HRS.     
This study also has several limitations. First, while the parameters describing growth of 
frailty propensity over time were represented as latent factors, frailty itself was considered as a 
dichotomous, observed variable. To the extent that definitional criteria imperfectly measure the 
underlying frailty construct, our model results may misrepresent the relationship between frailty 
and other variables. However, frailty status for each of the three definitions was dichotomized 
according to standard criteria used extensively in previous research (21, 24, 48-50). Also, 
categorization of frailty as a discrete condition renders it clinically sensible as a basis for 
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treatment and intervention. Second, the measure of depression used in this study, the CESD, is 
not designed as a substitute for clinician diagnosis of major depression, and may not accurately 
distinguish depressed from non-depressed individuals. Nonetheless, the CESD is among the most 
widely used measures for depressive symptoms in the general community and thus its 
relationship with common measures of frailty is of research significance. Furthermore, the CESD 
has moderate diagnostic agreement with structured instruments for the assessment of major 
depression such as the CIDI (36, 37) and elevated depressive symptoms indicated by this scale 
have been associated with a host of adverse health outcomes that are also predicted by more 
clinically-validated metrics of depression (103, 104). Finally, the analytical sample was restricted 
to participants who were interviewed in each wave of the HRS from 2004 to 2012. By excluding 
participants lost to follow-up, it is possible that the study sample was healthier and less frail than 
individuals in the general population. Because both frailty status and adverse health outcomes are 
associated with increased likelihood of mortality, conditioning analysis on study retention may 
introduce bias by diminishing the observed relationship between frailty, depression, and adverse 
health outcomes. Despite this, the current study found a robust association between frailty and 
adverse health outcomes across multiple definitions of frailty. A more comprehensive 
understanding of this relationship could be gained by future studies accounting for competing 
risks such as mortality (105).    
 In summary, these results provide another step in understanding frailty’s role as a 
measure of vulnerability in older adults. LGCM showed that more rapid development of frailty, 
as measured by three common definitions, was associated with propensity for falls and nursing 
home stays. Furthermore, models suggest that depression plays a substantial role in explaining 
the risk of poor health conferred by frailty, regardless of how it is operationalized. Results 
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indicate the need for interdisciplinary research, and inter-professional collaboration, to promote 
health and well-being in later life.  
  
 
 
80 
 
Table 4.1. Baseline (Wave 2004) sample characteristics by frailty definition 
  Characteristics among Frail Older Adults 
 Total 
Functional  
Domains 
Medical 
Burdens 
Biological 
Syndrome 
 
N=10,611 
Frail  
N = 1,768 
Frail  
N = 2,903 
Frail  
N = 864 
Characteristic 
% or  
Mean (sd) 
% or  
Mean (sd) 
% or  
Mean (sd) 
% or  
Mean (sd) 
         
Age (yrs) 67.3 (7.9) 69.5 (8.7) 68.1 (8.2) 69.5 (9.2) 
Female 60.7 66.7 72.8 70.1 
Race     
White  84.0 75.3 81.1 83.7 
Black  13.5 21.4 16.0 14.1 
Other 2.4 3.2 3.0 2.2 
Education (>12 yrs) 43.0 27.2 32.6 30.6 
Household Poverty  7.7 16.6 12.8 16.2 
Marital Status     
Married/partnered 69.2 57.3 61.9 59.6 
Separated/divorced 10.8 13.8 13.5 14.4 
Widowed 17.3 25.2 21.6 22.6 
Health Insurance     
Medicare 60.8 75.4 69.3 73.1 
Medicaid 6.4 17.4 13.3 17.2 
Private 19.6 19.0 20.2 19.4 
Current smoker 12.4 15.3 14.4 15.5 
1 Biological syndrome: frail = 3 or more symptoms  
2 Medical burdens: frail = index score >.25  
3 Functional domains: frail = 2 or more symptoms   
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Table 4.2. Proportion frail by frailty definition and wave  
 Frailty Definition 
 
Functional 
Domains 
Medical 
Burdens 
Biological 
Syndrome 
Characteristic N (%) N (%) N (%) 
     
Wave 1 (2004)    
Frail  1,768 (17.1) 2,903 (27.4) 864 (8.4) 
Intermediate  3,510 (33.1) 2,605 (24.5) 3,397 (32.0) 
Wave 2 (2006)    
Frail  1,978 (19.0) 3,337 (31.5) 1,331 (12.5) 
Intermediate  3,612 (34.0) 2,839 (26.8) 4,061 (38.3) 
Wave 3 (2008)    
Frail  2,231 (21.4) 3,857 (36.4) 1,649 (15.8) 
Intermediate  3,790 (35.7) 2824 (26.6) 4,171 (39.3) 
Wave 4 (2010)    
Frail  2,906 (27.9) 4,159 (39.2) 2,043 (19.3) 
Intermediate  3,705 (34.9) 2,756 (26.0) 4,795 (45.2) 
Wave 5 (2012)    
Frail  3,482 (33.8) 4,697 (44.3) 2,130 (20.7) 
Intermediate  3,629 (34.2) 2,566 (24.2) 4,669 (44.0) 
    
1 Biological syndrome: frail = 3 or more symptoms; intermediate = 1 or 2 
symptoms 
2 Frailty index: frail = index score >.25; intermediate = index score >.15  
3 Functional domains: frail = 2 or more symptoms; intermediate = 1 
symptom 
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Table 4.3. Unconditional latent growth models of frailty and adverse health outcomes 
  
Functional 
Domains 
Medical  
Burdens 
Biological  
Syndrome 
Nursing Home  
Stay 
Serious  
Falls 
  Estimate 
p-
Value Estimate 
p- 
Value Estimate 
p- 
Value Estimate 
p- 
Value Estimate 
p- 
Value 
Model Fit Statistics           
CFI 0.995 --- 0.999 --- 0.955 --- 0.995 --- 0.982 --- 
TLI 0.992 --- 0.999 --- 0.925 --- 0.991 --- 0.971 --- 
RMSEA 0.042 --- 0.036 --- 0.069 --- 0.019 --- 0.023 --- 
           
Means           
Slope  0.182 <.001 0.078 <.001 0.375 0.010 -0.032 0.763 -0.362 0.169 
Intercept 0 --- 0 --- 0 --- 0 --- 0 --- 
           
Variances           
Slope  0.019 <.001 0.031 <.001 0.036 0.049 0.809 <.001 0.733 <.001 
Intercept 0.666 <.001 0.887 <.001 0.880 <.001 0.098 0.003 0.141 0.063 
           
Covariances           
Slope with Intercept -0.096  <.001 0.015 0.361 0.166 0.041 -0.016 0.578 -0.044 0.169 
CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; RMSEA: Root-mean-square error of approximation 
All p-values are two-tailed 
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Table 4.4. Growth parameter estimates, model fit criteria from conditional latent growth 
models with time-invariant predictors 
  
Functional 
Domains 
Medical  
Burdens 
Biological 
Syndrome 
Model Fit Criteria Estimate 
p-
Value Estimate 
p-
Value Estimate 
p-
Value 
CFI 0.990 --- 0.999 --- 0.953 --- 
TLI 0.983 --- 0.998 --- 0.923 --- 
RMSEA 0.020 --- 0.015 --- 0.028 --- 
       
Growth Parameters             
Random effect mean       
Slope  0.195 <.001 0.117 <.001 0.060 <.001 
Intercept 0.162 <.001 0.119 <.001 0.271 <.001 
Variances       
Slope  0.076 <.001 0.048 <.001 0.774 0.049 
Intercept 0.735 <.001 0.904 <.001 1.154 <.001 
Covariances       
Slope with Intercept 0.039 <.001 0.045 0.361 0.268 0.012 
CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; RMSEA: Root-mean-square error 
of approximation; All p-values are two-tailed 
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Table 4.5. Relationship between time-invariant predictors and initial level of and change 
in level of frailty 
  
Functional 
Domains 
Medical 
Burdens 
Biological 
Syndrome 
Covariates β 
p- 
Value β 
p-
Value β 
p- 
Value 
Intercept on covariate       
Gender 0.079 0.003 0.401 <.001 0.201 <.001 
Race (ref: white)       
Black 0.278 <.001 0.032 0.321 0.026 0.558 
Other 0.336 <.001 0.051 0.430 0.050 0.546 
Divorced (ref: married) 0.130 0.001 0.203 <.001 0.178 <.001 
Widow (ref: married) 0.091 0.012 0.043 0.214 -0.043 0.353 
Age (ref: 55-65 yrs)       
65 to 75 yrs 0.240 <.001 0.188 <.001 -0.062 0.094 
75 to 85 yrs 0.472 <.001 0.317 <.001 0.301 <.001 
85+ yrs 0.643 <.001 0.505 <.001 0.563 <.001 
Education (ref: HS or less) -0.381 <.001 -0.296 <.001 -0.230 <.001 
Current smoker 0.198 <.001 0.151 <.001 0.157 <.001 
Poverty 0.531 <.001 0.433 <.001 0.449 <.001 
       
Slope on covariate       
Gender -0.007 0.539 0.022 0.209 0.276 0.001 
Race (ref: white)       
Black 0.040 0.100 -0.003 0.775 0.107 0.024 
Other 0.042 0.231 -0.041 0.040 0.072 0.361 
Divorced (ref: married) 0.008 0.667 0.021 0.155 0.179 0.010 
Widow (ref: married) 0.028 0.110 0.034 0.007 0.163 <.001 
Age (ref: 55-65 yrs)       
65 to 75 yrs 0.087 0.002 0.095 <.001 0.626 <.001 
75 to 85 yrs 0.290 <.001 0.201 <.001 1.117 <.001 
85+ yrs 0.448 <.001 0.191 <.001 1.151 <.001 
Education (ref: HS or less) -0.100 0.004 -0.018 0.197 -0.368 <.001 
Current smoker 0.036 <.001 0.032 0.015 0.277 0.001 
Poverty 0.132 0.007 0.026 0.237 0.265 0.012 
CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; RMSEA: Root-mean-square error of 
approximation; All p-values are two-tailed 
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Table 4.6. Parallel process models adjusting for time invariant covariates and time-varying 
depression (Outcome: nursing home admission) 
  
Functional 
Domains 
Medical  
Burdens 
Biological 
Syndrome 
  Estimate 
p- 
Value Estimate 
p-
Value Estimate 
p- 
Value 
Model Fit Statistics       
CFI 0.993 --- 0.998 --- 0.970 --- 
TLI 0.989 --- 0.997 --- 0.952 --- 
RMSEA 0.012 --- 0.012 --- 0.018 --- 
        
Parameter β 
p- 
Value β 
p-
Value β 
p- 
Value 
Growth parameter regressions 
unadjusted for depression       
Frailty Intercept on NH Slope 0.036 0.227 -0.011 0.620 0.002 0.933 
Frailty Slope on NH Slope 0.594 <.001 0.889 <.001 0.333 <.001 
Frailty Intercept with NH 
Intercept 0.200 <.001 0.331 <.001 0.311 <.001 
       
Growth parameter regressions 
adjusted for depression       
Frailty Intercept on NH Slope 0.009 0.986 0.002 0.998 -0.011 0.982 
Frailty Slope on NH Slope 0.476 0.857 0.771 0.853 0.251 0.832 
Frailty Intercept with NH 
Intercept 0.170 <.001 0.350 <.001 0.299 0.002 
              
Parameter log odds 
p- 
Value log odds 
p-
Value log odds 
p- 
Value 
Frailty regression on time-varying 
depression       
Time 1 0.510 <.001 0.581 <.001 0.522 <.001 
Time 2 0.405 <.001 0.580 <.001 0.545 <.001 
Time 3 0.568 <.001 0.635 <.001 0.721 <.001 
Time 4 0.566 <.001 0.655 <.001 0.611 <.001 
Time 5 0.791 <.001 0.894 <.001 0.723 <.001 
CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; RMSEA: Root-mean-square error of 
approximation 
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Table 4.7. Parallel process models adjusting for time invariant covariates and time-varying 
depression (Outcome: serious fall)  
  
Functional 
Domains 
Medical  
Burdens 
Biological 
Syndrome 
  Estimate 
p-
Value Estimate 
p-
Value Estimate 
p-
Value 
Model Fit Statistics       
CFI 0.988 --- 0.996 --- 0.962 --- 
TLI 0.981 --- 0.994 --- 0.942 --- 
RMSEA 0.015 --- 0.016 --- 0.020 --- 
        
Parameter β 
p-
Value β 
p-
Value β 
p-
Value 
Growth parameter regressions 
unadjusted for depression       
Frailty Intercept on Fall Slope 0.403 0.002 0.281 0.001 0.192 0.007 
Frailty Slope on Fall Slope 1.759 <.001 1.782 <.001 1.306 <.001 
Frailty Intercept with Fall Intercept 0.161 <.001 0.221 <.001 0.164 <.001 
       
Growth parameter regressions adjusted 
for depression       
Frailty Intercept on Fall Slope 0.211 0.021 0.192 0.009 0.093 0.085 
Frailty Slope on Fall Slope 1.193 0.001 1.366 <.001 0.977 0.001 
Frailty Intercept with Fall Intercept 0.149 <.001 0.200 <.001 0.120 0.001 
              
Parameter log odds 
p-
Value log odds 
p-
Value log odds 
p-
Value 
Frailty regression on time-varying 
depression       
Time 1 0.510 <.001 0.582 <.001 0.522 <.001 
Time 2 0.410 <.001 0.582 <.001 0.563 <.001 
Time 3 0.581 <.001 0.640 <.001 0.746 <.001 
Time 4 0.585 <.001 0.661 <.001 0.638 <.001 
Time 5 0.827 <.001 0.905 <.001 1.800 <.001 
CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; RMSEA: Root-mean-square error of 
approximation 
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Figure 4.1. Heuristic example of unconditional latent growth curve model for functional domains 
frailty 
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Figure 4.2. Heuristic example of conditional latent growth curve model for functional domains 
frailty 
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Figure 4.3. Parallel process model of functional domains frailty and nursing home stays 
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Figure 4.4. Parallel process model adjusted for time-varying depression 
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Figure 4.5. Sample proportions and model estimated probabilities for functional domains frailty 
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Figure 4.6. Sample proportions and model estimated probabilities for medical burdens frailty 
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Figure 4.7. Sample proportions and model estimated probabilities for biological syndrome frailty 
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Afterword 
 
 
 Findings from this project have important implications for promoting health and well-
being among older adults. By clarifying the associations between frailty and depression, this 
project informs design of preventive approaches to addressing physiological and psychosocial 
vulnerability. This project also highlights important connections between geriatric and 
psychiatric research. Bridging these lines of investigation will provide a richer understanding of 
the causes and correlates of adverse health events in late life.    
 Consistent across the three studies that constitute this project, frailty and depression were 
found to be highly interrelated syndromes. These findings suggest that frailty and depression 
should not be viewed as distinct syndromes but as overlapping and fundamentally linked 
conditions. A common approach to research related to frailty definition is to exclude individuals 
with depression from analysis; however, studies that aim to examine frailty independently from 
depression may imply an artificial distinction between these two syndromes and may draw 
incorrect inferences regarding the consequences and causes of frailty (Chapter 4). A more 
promising approach to research is to investigate frailty and depression as joint expressions of 
underlying decline. This approach is reflected in Hajjar et al. (2009), which identified an age-
related syndrome characterized by symptoms of frailty and depression that was independently 
related to cardiovascular disorders (67). The second-order factors detailed in Chapter 3 of this 
project provide similar implications of an underlying process influencing both frailty and 
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depression. Therefore this project supplements current literature by organizing key findings 
within an explanatory structural model that serves as a target for future investigation. The 
robustness of findings using three conceptually distinct definitions of frailty offers rationale for 
refocusing the study of frailty and depression on their putative substrates. Study of the 
mechanisms and biologically plausible explanations of comorbidity of frailty and depression 
may lead to more effective ways to prevent and or treat these conditions jointly and 
independently. 
  This project likewise serves to unite research in frailty with guiding principles from 
geriatric psychiatry. In geriatric psychiatry, generative hypotheses regarding the causes of and 
alternate presentations of depression among older adults have led to important advances in 
understanding of depression. For instance, the ‘vascular depression hypothesis,’ which proposes 
that vascular mechanisms underlie many cases of late-onset depression, has guided search for 
causal explanations of depression among older adults (88, 106). Likewise, evidence suggests that 
depression among older adults is often characterized by a relative lack of mood-related 
symptoms and a preponderance of vegetative or somatic symptoms such as sleep disturbance and 
fatigue (41, 96). This phenomenon, termed ‘depression without sadness,’ has informed the 
development of more accurate survey measurements of depression among older adults and has 
provided avenues for future investigations of age differences in depression (41, 96). Though 
these findings from geriatric psychiatry may signal potential connections between frailty and 
depression, research on frailty has progressed, for the most part, independent of input from this 
related field. By presenting a basis for comparison between frailty and depression research, the 
current project may help to encourage refinement of the frailty concept and therefore more 
accurate identification of frail older adults. More accurate identification of frailty would 
 
 
96 
 
ostensibly improve recommendations for care and allocation of limited health resources for older 
adults. 
 The current project has implications for clinicians seeking to provide effective therapy for 
frail older adults. Comorbidity of frailty and depression may signal an elevated risk of adverse 
health outcomes (45). Frail older adults with depression may benefit from more holistic 
approaches to care which address not only physiological vulnerability but also the psychosocial 
vulnerabilities represented by depression (45). In support of this idea, the current project found 
that both depression and frailty were independently associated with risk of adverse health 
outcomes and that both conditions explained variations in who did and did not experience 
adverse health outcomes over time. Furthermore, frailty may limit effectiveness of or adherence 
to depression treatment, suggesting again that frailty and depression must not be considered 
independently of one another in clinical settings (43, 44). To our knowledge, no studies have 
investigated treatment approaches specifically aimed at addressing frailty and depression 
concurrently. A second implication of the current project is that greater rates of change in frailty 
were significantly associated with more rapid increase in the likelihood of experiencing adverse 
health outcomes. Thus, frailty trajectories are themselves important predictors of poor health 
apart from frailty status. More rapid accumulation of frailty symptoms over time may signal 
greater risk of adverse health outcomes. This suggests that delaying or preventing frailty 
symptoms may help to prevent adverse health outcomes, even among those who would not be 
considered frail by standard cut-off criteria. Tracking longitudinal changes in symptoms of 
frailty may then provide more nuanced measures of vulnerability. 
 Much is still unknown about how to best identify and to care for frail older adults. Future 
research should continue to seek the development of a unified frailty definition and to evaluate 
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approaches to caring for frail older adults. The current project provides a foundation for future 
research by elucidating frailty’s relationship with depression and describing the joint role of 
these syndromes in determining poor health among older adults. The potential public health 
benefit of frailty will only be realized when conceptual issues are resolved.   
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Appendix 
 
    
Appendix 3.1. Deficits used to define the frailty index (Chapter 3) 
Variable name  Operationalization in HRS 
Problems getting dressed Some difficulty dressing self 
Problems with bathing Some difficulty bathing, shower 
Toileting problems Some difficulty using toilet 
Problems cooking Some difficulty preparing hot meals 
Problems going out alone Difficullty shopping for groceries 
Change in everyday 
activities 
Change in activities of daily living 
Impaired mobility  Some difficulty walking across room, walking several blocks, 
climbing stairs 
Falls Any reported falls past 2 years 
Poor muscle tone limbs Difficulty in large muscle activities (e.g. stooping, chair stand, 
kneeling, pushing large object) 
Poor limb coordination Difficulty in fine motor skills such as picking up a dime, eating 
and dressing 
Bradykinesia of limbs Slow walking speed  
Musculoskeletal problems Arthritis, hernia, rheumatism, paralysis, etc. 
Hypertension Reported high blood pressure 
Myocardial infarction Ever had heart attack 
Congestive heart failure Ever had heart failure 
Arrhythmia Ever had abnormal heart rhythm 
Other cardiac problems Ever had angina 
History of stroke Ever had a stroke 
History of diabetes 
mellitus 
Ever had diabetes 
Long-term memory 
impairment 
Problem with dementia 
Memory changes Memory worse than two years ago 
History of Parkinson's 
disease 
Ever have Parkinson's disease 
Headache Persistent headache 
Trouble sleeping Trouble falling asleep or waking up during night 
Tiredness all the time Persistent or troublesome fatigue or exhaustion 
Syncope or blackouts Dizziness, blackouts, meningitis, other neurological problems 
Lung problems Ever have lung disease 
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Respiratory problems Persistent couch/wheeze/flem or asthma, emphysema, chronic 
bronchitis  
Other psychiatric 
condition  
Psychiatric conditions not including depression and GAD 
Feeling sad, blue, 
depressed 
Felt depressed in past year 
Gastrointestinal problems E.g ulcers, colitis, gastritis, diverticulosis  
Skin condition E.g. dermatitis, eczema, rashes 
Thyroid trouble Any thyroid problem 
Incontinence Any reported incontinence past 12 months 
Malignant disease Ever had cancer 
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Appendix 3.2. Model fit indices from uni-dimensional factor analyses 
 
Biological 
syndrome Frailty index 
Functional 
domains CESD 
CFI 0.991 0.953 0.97 0.953 
TLI 0.984 0.95 0.91 0.962 
RMSEA 0.013 0.029 0.036 0.082 
Exploratory analysis found that the model fit of the medical burdens frailty 
model was significantly improved when modeled as a second order factor with 
three sub-dimensions generally corresponding to activities of daily living, 
cardiovascular and neurological symptoms (Appendix 3.1); however, because 
frailty is commonly used as a uni-dimensional factor in practice, the frailty 
index was modeled as such in subsequent analyses.   
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Appendix 4.1. Criteria used to define physical measures symptoms of biological syndrome 
model frailty 
Grip strength, stratified by gender and body mass index (BMI)       
Men   Cutoff for grip strength (kg) criterion   
BMI < 24   < 29      
BMI 24.1-26  < 30      
BMI 26.1-28  < 30      
BMI > 28   < 32      
         
Women         
BMI < 23   < 29      
BMI 23.1-26  < 30      
BMI 26.1-29  < 30      
BMI > 29   < 32      
         
Walking speed, stratified by gender and height         
Men   
Cutoff time for 15 feet walking course (scaled 
to 2.5 meter for HRS) 
Height < 173 cm  > 7 seconds     
Height > 173 cm  > 6 seconds     
         
Women         
Height < 159 cm  > 7 seconds     
Height > 159 cm   > 6 seconds         
All cutoff criteria are derived from Fried et al. (2001)         
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Appendix 4.2. Deficits used to define the frailty index, medical burdens model (Chapter 4) 
Variable name  Operationalization in HRS 
Problems getting dressed Some difficulty dressing self 
Problems with bathing Some difficulty bathing, shower 
Toileting problems Some difficulty using toilet 
Problems cooking Some difficulty preparing hot meals 
Problems going out alone Difficullty shopping for groceries 
Change in everyday 
activities 
Change in activities of daily living 
Impaired mobility  Some difficulty walking across room, walking several blocks, climbing 
stairs 
Falls Any reported falls past 2 years 
Poor muscle tone limbs Difficulty in large muscle activities (e.g. stooping, chair stand, kneeling, 
pushing large object) 
Poor limb coordination Difficulty in fine motor skills such as picking up a dime, eating and 
dressing 
Hypertension Reported high blood pressure 
Myocardial infarction Ever had heart attack  
Congestive heart failure Ever had heart failure  
Other cardiac problems Ever had angina  
History of stroke Ever had a stroke  
History of diabetes 
mellitus 
Ever had diabetes  
Long-term memory 
impairment 
Problem with dementia 
Memory changes Memory worse than two years ago 
Headache Persistent headache  
Trouble sleeping Trouble falling asleep or waking up during night 
Tiredness all the time Persistent or troublesome fatigue or exhaustion 
Lung problems Ever have lung disease 
Respiratory problems Persistent couch/wheeze/flem or asthma, emphysema, chronic bronchitis  
Other psychiatric 
condition  
Psychiatric conditions not including depression and GAD 
Feeling sad, blue, 
depressed 
Felt depressed in past year 
Incontinence Any reported incontinence past 12 months 
Malignant disease Ever had cancer  
Arthritis Reported arthritis this wave 
Trouble with pain Often troubled with pain 
Back pain or back 
problems Back pain or problems 
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Appendix 4.3. Growth parameter estimates, model fit criteria from 
conditional latent growth models with time-invariant predictors 
  
Nursing Home 
Stay 
Serious  
Fall 
Model Fit Criteria Estimate 
p-
Value Estimate 
p-
Value 
CFI 0.997 --- 0.978 --- 
TLI 0.995 --- 0.963 --- 
RMSEA 0.005 --- 0.013 --- 
     
Growth Parameters         
Random effect mean     
Slope  -0.125 0.545 -3.233 0.003 
Intercept 0.132 <.001 1.413 <.001 
Variances     
Slope  0.109 0.029 1.459 0.039 
Intercept 0.646 <.001 1.215 <.001 
Covariance     
Slope with Intercept -0.044 0.080 -0.087 0.261 
CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; RMSEA: 
Root-mean-square error of approximation 
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Appendix 4.4. Growth parameter estimates, model fit criteria from 
conditional latent growth models with time-invariant predictors 
  
Nursing Home 
Stay 
Serious  
Fall 
Covariate Effects β 
p-
Value β 
p-
Value 
Intercept on covariate     
Gender 0.243 0.001 0.284 <.001 
Race (ref: white)     
Black -0.037 0.677 
-
0.126 0.083 
Other -0.558 0.042 
-
0.194 0.27 
Divorced (ref: married) 0.253 0.006 0.045 0.601 
Widow (ref: married) 0.178 0.013 0.095 0.106 
Age (ref: 55-65 yrs)     
65 to 75 yrs 0.365 <.001 1.909 <.001 
75 to 85 yrs 0.563 <.001 2.013 <.001 
85+ yrs 0.762 <.001 2.377 <.001 
Education (ref: HS or less) -0.016 0.791 0.034 0.481 
Current smoker 0.056 0.579 0.041 0.612 
Poverty -0.034 0.755 0.153 0.065 
      
Slope on covariate     
Gender -0.029 0.240 0.416 0.002 
Race (ref: white)     
Black 0.001 0.982 
-
0.399 0.002 
Other 0.065 0.479 
-
0.439 0.030 
Divorced (ref: married) 0.011 0.763 0.151 0.087 
Widow (ref: married) 0.026 0.425 0.118 0.105 
Age (ref: 55-65 yrs)     
65 to 75 yrs 0.136 0.025 0.545 0.042 
75 to 85 yrs 0.323 0.006 0.908 0.014 
85+ yrs 0.464 0.006 1.179 0.013 
Education (ref: HS or less) -0.025 0.297 
-
0.041 0.405 
Current smoker 0.018 0.600 
-
0.218 0.015 
Poverty 0.129 0.010 0.109 0.269 
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